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Many viruses require chaperones during viral replication. I investigated the 
involvement of HSP70 family chaperones in reovirus replication and assembly. 
Assembly and replication occurs in the cytosol of reovirus-infected cells within 
structures called viral factories (VFs). The nonstructural protein μNS forms the matrix 
of VFs. The eight structural proteins that assemble the inner core of the double-layered 
virion are recruited to VFs by specific interactions with μNS. However, it is unknown 
how the outer capsid proteins µ1 and σ3 are recruited to VFs. Using biochemical and 
cell biological approaches I found that recruitment of μ1 to VFs requires assembly 
with its partner protein σ3. In addition, I found that the μ1:σ3 complex and µ1 alone, 
interact with the cellular chaperone Hsc70. Moreover, the subcellular distribution of 
Hsc70 correlated with that of μ1 in reovirus infected cells and Hsc70 also co-localized 
with ectopically expressed μNS. The Hsc70-µNS interaction did not require the 
chaperone ATPase function, suggesting that µNS is not a substrate for Hsc70. The 
formation of viral factory-like structures by µNS was not affected after siRNA-
mediated knockdown of Hsc70. These findings suggest that Hsc70 facilitates assembly 
of µ1:σ3 complexes and is likely involved in their subsequent recruitment to VFs. The 
specific interaction of Hsc70 with μNS may be involved in assembly of viral particles, 
but as in other viruses could also be involved in other replicative processes. 
The last part of my thesis focused on reovirus-induced apoptosis. Apoptosis is 
induced by µ1 and occurs late in infection, but the regulatory mechanisms that prevent 
premature apoptosis induction by µ1 are poorly understood. I found that µ1 was 
cleaved by caspases upon µ1-induced apoptosis. This represents a negative feedback 
iii 
 loop where µ1-induced apoptosis leads to degradation of µ1 by caspase cleavage. I 
also found that µ1 was ubiquitinated, suggesting proteasomal degradation as another 
means to regulate µ1-induced apoptosis. Interestingly, the extent of µ1 ubiquitination 
was influenced by caspase activity, indicating a link between the two phenotypes. 
These findings suggest caspase cleavage and ubiquitination of µ1 as mechanisms to 
regulate µ1-induced apoptosis, and they reveal a link between these so far unrelated 
events. 
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The Reoviridae comprise a number of viruses that share as their core 
characteristic a double-stranded RNA (dsRNA) genome (86, 89). Members of this 
family infect many of different species including mammals, birds, reptiles, fish, 
molluscs, arthropods, but also fungi and plants. A total of 15 genera are recognized 
and have been so far grouped into turreted and nonturreted viruses based on the 
presence of a turret-like protrusion at the five-fold axis of symmetry of the virus 
capsid. Recently the formation of two subfamilies, named Sedoreovirinae (sedo, 
smooth : Latin) and Spinareovirinae (spina, spike : Latin) reflecting this informal 
grouping has been ratified (15). The mammalian orthoreoviruses, the prototype 
members of the Reoviridae, which will be the subject of this thesis, belong to the 
genus Orthoreovirus. These are the initially identified “reoviruses” that were isolated 
from patients with mild upper respiratory infections or gastroenteritis. Due to the fact 
that these viruses could not be linked as causative agents to these illnesses the name 
reovirus was proposed as an acronym for “respiratory enteric orphan virus”. 
Subsequently identified other members of the Reoviridae, on the other hand, are well 
established pathogens, like rotaviruses and Bluetongue virus of the genus Rotavirus 
and Orbivirus, respectively. The hallmark feature of the Reoviridae is their dsRNA 
genome which is segmented into 9-12 pieces depending on the genus. The segments 
are grouped into three categories, L (large), M (medium) and S (small) based on their 
length (89). Each segment encodes one to three, but mostly only one, protein on the 
positive sense RNA strand of one dsRNA. The genome is enclosed in non-enveloped 
capsids consisting of two or three concentric protein layers with icosahedral symmetry 
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(52, 68, 81). The average diameter of 60 to 85 nm does not include a fiber protein that 
extends from the surface of some family members. The newly discovered genus 
Dinovernavirus has only one protein shell and is therefore smaller with a diameter of 
about 50 nm (3). 
 
The mammalian orthoreoviruses 
As mammalian orthoreoviruses (from now on named reoviruses) are the 
prototype members of the family Reoviridae and as the subject of this thesis, will be 
discussed in more detail. The mature reovirus virion consists of 8 structural proteins 
that are arranged in two concentric protein shells (Figure 1.1). 120 copies of λ1 form 
the inner layer or core, which exhibits T=1 symmetry (also termed T=2 as the 
asymmetric unit is comprised of a parallel, asymmetric λ1 dimer) (42). On top of the 
λ1 shell sit two core proteins, σ2 and λ2. σ2 decorates the λ1 shell and is thought to 
function as a stabilizing clamp (81). λ2 occurs as pentamers at the five-fold axis of 
symmetry and forms the turrets that are present in the Spinareovirinae. Inside the core, 
slightly offset from each of the five-fold axis of symmetry, is thought to sit one λ3 
protein, which is the RNA-dependent RNA polymerase (RdRp) (96, 99). λ3 is likely 
associated with the protein µ2, which is proposed to act as a cofactor for the RdRp 
(53). The exact location and quantity of µ2 within core particles is not known for 
certain. In between the λ2 turrets and atop the λ1 – σ2 core sits the outer capsid. This 
second protein shell has T=13 symmetry and is mainly composed of µ1 and σ3 (59). 
These two proteins form a heterohexamer with three intertwined µ1 monomers at the 
base and three σ3 monomers binding in between two µ1 proteins at the top of the 
complex (Figure 1.2). 600 copies of each µ1 and σ3 make up 200 heterohexamers that 
decorate the underlying core (67, 68). The vacant spaces due to the missing 180 
subunits that would be expected in a T=13 symmetry (13 x 60 = 780) are occupied by 
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the pentameric λ2 turrets, which extend from the core, through and beyond the outer 
capsid layer. The center of these turrets anchors the attachment protein σ1, which 
consequently occurs at the five-fold axis of symmetry and is present as a homotrimer. 
The σ1 encoding genome segment S1 is the serotype-determining gene and shows the 
least sequence conservation (26% to 49%) compared to all other reoviral genes (70.6% 
to 97.8%) (29, 74). Based on their S1 sequence, reovirus isolates are separated into 
three serotypes whose prototype representatives are type 1 Lang (T1L), type 2 Jones 

























Figure 1.1: Structure and composition of different reovirus particles (30). A) 
Illustrations of virion, ISVP and core particles were created from cryo-EM and image 
reconstruction. Each particle is oriented with the five fold axis of symmetry at the 








Figure 1.2: Structures of outer capsid proteins σ3 and µ1. A) σ3 monomer, B) µ1 
monomer with fragments µ1N in green, δ in blue and Φ in red. C) heterohexamer in 
side view; One µ1 monomer colored in blue, others in grey to illustrate twisting of the 
three subunits. D) heterohexamer in top view. The monomeric representations of µ1 
and σ3 were taken from the heterohexamer structure (PDB 1JMU) (59). Originally, σ3 





Reoviruses are ubiquitous and are frequently isolated from fresh and waste 
waters. Epidemiologic studies found that most individuals test positive for antibodies 
against all three serotypes by the end of childhood (55, 88). One study showed that 
more than 70% of children over three years old had anti-reovirus antibodies (57). 
The reovirus lifecycle begins with the attachment of σ1 to its receptors sialic 
acid and junctional adhesion molecule A (JAM-A) on the surface of a host cell (see 
Figure 1.3 for simplified reovirus lifecycle) (13, 86). Following attachment, virions are 
endocytosed, a process that possibly is mediated by interactions of the λ2 turret with 
β1 integrin. Within endosomes partial proteolysis of the outer capsid occurs. This is 
mediated by cathepsins that are activated by the acidic pH within endosomes (32, 62, 
63, 94). Proteolysis of the virion can also take place in the extracellular environment 
of the gut or lungs bypassing endocytic uptake and allowing for direct infection from 
the plasma membrane. Proteolytic processing of virions is necessary in order to 
activate the outer capsid protein µ1 for membrane penetration. To penetrate 
membranes, µ1 undergoes proteolytic cleavage and conformational changes. In 
virions, µ1 is shielded by a coat of σ3 which prevents the untimely implementation of 
these processes. As a result of the proteolytic digestion, σ3 is released from the virion, 
which is now called an intermediate/infectious subviral particle (ISVP) (30). Due to 
the loss of its protector protein σ3, µ1 undergoes distinct conformational changes. An 
apparently autocatalytic cleavage of µ1 occurs at amino acid (aa) N42 generating the 
N-terminal fragment, µ1N, and the remaining part called µ1C (75, 76). A second 
cleavage event at aa Y581 or R584 is catalyzed by chymotrypsin or trypsin in vitro, 
respectively and yields the central δ fragment and the C-terminal Φ fragment (17). 
Both the myristoylated µ1N and the Φ fragment are released from the ISVP and have 
been associated with membrane penetration although the exact mechanism remains to 
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be elucidated. The loss of the σ1 attachment protein and the release of the δ fragment 
of µ1 lead to the deposition of the core in the cytoplasm of the infected cell (18). 
These cores are transcriptionally active and produce viral mRNAs, which exit 
the core through radial channels in the λ2 turrets at the five-fold axis of symmetry. 
These channels are open only in core particles, but not in virions or ISVPs. λ2 
undergoes a conformational change during the ISVP-to-core particle transition which 
leads to the opening of the turret by an up- and outward rotation of λ2 domains (30). 
As they pass through the λ2 turret the non-polyadenylated mRNAs acquire a 5′ cap 
structure that enhances their translation by the cellular machinery (22, 60, 61). 
One of the translated proteins is µNS, a non-structural protein that forms the 
matrix of the viral factories which are thought to be the location of ongoing viral 
replication and assembly (82). The primary mRNA transcripts are detectable by 2 h 
after infection, peak after 6 – 8 h, and are undetectable by 12 h post infection (hpi) if 
overall protein synthesis is inhibited with cycloheximide. Inhibition of protein 
synthesis prevents the formation of new core particles which contribute to mRNA 
transcription. The vast majority of viral mRNAs (95%) are secondary transcripts and 
stem from transcriptase particles. These are newly assembled core particles that are 
coated with µNS and seem to be hindered in their acquisition of the outer capsid (72). 
The secondary transcripts appear 4 – 6 hpi and decrease after reaching a maximum at 














Figure 1.3: Reovirus lifecycle. Entry of virions occurs either by receptor-mediated 
endocytosis and endosomal proteolysis or after extracellular proteolysis generating an 
ISVP. After endosomal or plasma membrane penetration the transcriptionally active 
core arrives in the cytosol and primary, capped mRNAs are deposited in the cytosol. 
Viral proteins are translated and recruited to viral factories nucleated by µNS-bound 
cores. Newly assembled cores engage in negative sense RNA strand synthesis and 






 Generation of reovirus progeny virions 
The replication and assembly of reovirus progeny virions is thought to occur in 
viral factories (VFs) (82). These inclusion-like structures start out as small pin points 
very early in infection and expand throughout the infection. Individual VFs can fuse 
together and eventually the cytoplasm of the infected cell will be almost filled up with 
large viral factories (Parker, unpublished observation). VFs are not membrane-bound 
and consist of a matrix of the 80 kDa nonstructural protein µNS (10). VFs can be of 
filamentous or globular nature depending on the virus strain. T1L and T3DCD show a 
filamentous VF morphology, while T3DN exhibits globular VFs. This phenotypic 
difference in T3DN is due to a point mutation in the µNS-interacting protein µ2 which 
abrogates the association of µ2 with microtubules (78). If µNS is expressed by itself it 
will form viral factory-like structures (VFLs) that resemble VFs in infected cells (10). 
How µNS forms viral factories remains to be elucidated. By thin section electron 
microscopy the matrix of VFs appears to consist of fibrils that have a distinct kink, but 
as an atomic resolution structure of µNS is not available, the exact mechanism remains 
subject to speculation (26, 27, 90). It is thought that µNS forms oligomers that 
represent the building block of the viral factory matrix, but the nature of such 
oligomers is unknown. It has been shown that µNS can bind cores in vitro without 
negatively affecting their transcription or capping activity (9). µNS-bound cores might 
actually have a slightly enhanced capping activity (9). Furthermore, Broering et al. 
expressed µNS in cells allowing the formation of VFLs before inhibiting further 
protein synthesis with cycloheximide and infecting the cells with ISVPs. They found 
that the entering core particles were recruited to the pre-formed VFLs (8). These 
findings support the hypothesis that newly synthesized µNS binds to the infecting core 
particles and utilizes them as a nucleation factor for factory formation. In these 
 9
factories the following processes have to take place in order for new progeny virions 
to arise (order of listing does not imply chronology): i) assembly of λ1 and σ2 into the 
core shell, ii) incorporation of the λ3 polymerase and of µ2 into this shell, iii) 
packaging of one of each of the viral genes in form of [+]-RNA and synthesis of the 
negative sense RNA strand, iv) addition of the pentameric λ2 turrets onto the core 
shell, v) formation of the outer capsid consisting of µ1:σ3 heterohexamers and the 
attachment protein σ1 and vi) egress of virions. 
Recent findings put µNS at the center stage of virion assembly. Miller et al 
showed that µNS interacts with the structural proteins λ1, σ2, µ2, λ3 and λ2 as well as 
the nonstructural protein σNS via non-overlapping domains (Figure 1.4) (69). This 
means that all proteins that comprise the core particle are recruited to the viral 
factories. σNS has been found to bind to ssRNA and is implicated in the sorting and/or 
packaging of viral [+]-RNAs together with µNS and σ3 (2, 5, 40). All three proteins 
have been identified along with viral [+]-RNA in small nucleoprotein complexes, 
although the exact order of association is unclear. After a new core particle is 
assembled and the negative sense RNA strand has been synthesized it has two choices: 
a) remain as a transcriptase particle and keep producing [+]-RNAs that get translated 
into proteins and form new cores, or b) acquire the outer capsid thus shutting off 
transcription and mature into a full virion. µNS seems to play a role in this decision. 
Transcriptase particles isolated from infected cells show an association with µNS (72, 
102). Furthermore, in vitro experiments revealed that µNS-bound cores can still 
produce capped [+]-RNAs, but unlike non-µNS bound cores do not associate with 
outer capsid proteins to form virions (9, 72). Reovirus has to have evolved a 
mechanism that regulates the switch from transcription to assembly. If all cores 
remained associated with µNS in the viral factories, no fully assembled virions would 
be generated. On the other hand if all cores were to immediately be coated with the 
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outer capsid, the infection would be terminated prematurely as full virions are not 
transcriptionally active. To date no such mechanism has been elucidated, but I will 
propose a hypothesis in the final summary of this thesis based on my findings 
presented in chapter 2. 
 
 
Figure 1.4: Schematic representation of µNS and its binding sites for σNS, µ2, λ1, λ2, 
σ2, λ3 and reoviral cores. 
 
The recruitment of the major outer capsid proteins µ1 and σ3 to VFs is poorly 
understood. In a fully assembled virion the two proteins are associated into a 
heterohexamer with three intertwined µ1 monomers at the base and three σ3 
monomers decorating the spaces in between two µ1 subunits (59). This complex forms 
in the absence of other viral proteins in insect cells infected with recombinant 
baculovirus carrying the µ1- and σ3-encoding gene segments. The atomic structure of 
the µ1:σ3 complex has been solved and studied extensively (30, 59). However, where 
and when the µ1:σ3 heterohexamer assembles in an infected cell and how these 
proteins are recruited to viral factories is not clear. µ1 localizes to the endoplasmic 
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reticulum, mitochondria, lipid droplets and in infected cells also to viral factories (24). 
The localization to membranes and VFs is observed more frequently late in infection 
while at early time points µ1 is predominantly diffuse in the cytosol (24). This time-
dependent change in localization could suggest a mechanism by which µ1 is only 
recruited to VFs towards the end of the infectious cycle in order to prevent premature 
outer capsid assembly onto transcriptase particles. Experiments with a temperature 
sensitive mutant of σ3 (tsG453) have shown an accumulation of core-like particles in 
cells infected at the restrictive temperature (71).This finding indicates that µ1 and σ3 
are pre-assembled into heterohexamers before this complex is assembled onto the 
core; otherwise one would expect cores with some sort of coat of µ1. Chapter 3 will 
address some of the questions concerning the trafficking and assembly of µ1 and σ3. 
 
Chaperones 
The cytosol is a very crowded place. Assuming all proteins were distributed 
evenly, their concentration would be around 300 mg/ml (101), but considering that 
ribosomes can arrange into polysomes, local protein concentrations at the site of 
protein synthesis are likely to be even higher. This molecular crowding leads to an 
increased tendency of nascent proteins to engage in nonspecific protein interactions. 
But irregardless of the molecular crowding, the folding of a newly translated protein is 
not a trivial process. Most proteins contain more than one domain or folding unit 
which is approximately 100 – 200 amino acids long and has to be translated 
completely before folding can occur (43). This means that a significant portion of the 
polypeptide chain will remain unfolded and exposed to the crammed cytosol until the 
full domain has been translated. But also after an individual protein has successfully 
reached its native state, it might be destined to oligomerize and still display unburied 
hydrophobic regions which increases the risk of aggregation. Chaperones are 
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ubiquitous cellular proteins that help nascent polypeptides to fold properly as well as 
prevent protein subunits from aggregating by aiding the assembly of protein 
complexes, and even dissaggregating protein aggregates (11, 43, 87). Chaperones are 
also involved in the translocation of proteins across organellar membranes, signal 
transduction and the regulation of the cell cycle and apoptosis (6, 44, 73, 84). 
There are two major chaperone systems in the eukaryotic cell, the heat shock 
protein 70 (HSP70) and the chaperonin system (33, 36, 45, 83). Both of these systems 
are dependent on an ATP/ADP exchange cycle. In the ATP-bound state the substrate 
on/off rate of the chaperone is fast, while the rates are slow in the ADP-bound 
conformation (12). Chaperonins are barrel shaped protein complexes that facilitate 
protein folding inside their central cavity and thus are limited to substrates smaller 
than 60 kDa (65). Two groups can be distinguished depending on their association 
with a co-chaperone that serves as a lid on the barrel after substrate binding. Group I 
chaperonins like Hsp60 in eukaryotes and GroEL in E. coli interact with their “lids” 
Hsp10 and GroES, respectively, while group II chaperonins (for example TRiC/CCT 
in eukaryotes, thermosome in archaea) have a built-in lid. 
Members of the HSP70 chaperone system are proteins of approximately 70 – 
100 kDa. They consist of a nucleotide-binding domain (NBD) joined by a flexible 
linker to a substrate-binding domain (SBD) (34, 97, 100). HSP70 chaperones are not 
limited in their substrate size like the chaperonins as they bind relatively short, 
extended, hydrophobic segments of proteins. The major members of this family are 
the heat shock cognate protein 70 (Hsc70) in eukaryotes and its bacterial homologue 
DnaK in E. coli. These proteins are modulated in their activity by co-chaperones 
which also belong to the HSP70 chaperone system. Co-chaperones often display a 
modular composition containing a chaperone-interaction domain together with other 
motifs that can target them to a specific cellular compartment or enable them to recruit 
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other proteins besides chaperones. Thereby, co-chaperones can direct cytosolic 
chaperones to distinct locations and influence their local activity. In the following 
paragraph Hsc70 and its regulation by different co-chaperones will be discussed in 
more detail. 
 
Heat shock cognate protein 70 
The heat shock cognate protein 70 (Hsc70) is one of the most abundant cellular 
chaperones. It is constitutively expressed, but also has an inducible form, heat shock 
protein 70 (Hsp70) whose expression is upregulated under conditions of cellular stress 
such as starvation or heat shock, but also during bacterial and viral infections. Hsc70 
is structurally divided into two domains, the ~44 kDa nucleotide-binding domain 
(NBD, aa 1-383) or ATPase domain and the ~30 kDa substrate-binding domain (SBD, 
395-650) (Figure 1.5). Both domains are connected via a short, exposed linker (aa 
384-394) (50). The NBD consists of two lobes divided by a deep cleft at whose 
bottom the nucleotide binds (34). The SBD can be further divided into two 
subdomains, the 18 kDa minimal substrate-binding site and the 10 kDa C-terminal tail. 
The substrate-binding site is composed of two β sheets, each containing four β strands. 
The two β sheets are twisted and create a U-shaped groove which is the site of 
substrate binding (100). The 10 kDa C-terminal tail assumes an α-helical fold and acts 
in part as a lid over the substrate binding pocket by interacting with the upwards 
protruding loops connecting the β strands (65). The extreme C-terminus of Hsc70 has 
not been crystallized so far as this region seems to be highly flexible. These last 30-40 
amino acids are highly conserved among eukaryotic Hsc70 and contain several GGXP 






Figure 1.5: Structures of bovine Hsc70 (PDB 1YUW) and E. coli DnaK substrate-
binding domain (PDB 3DPP) (50, 58). A) Front and B) side view of ribbon structure 
of bovine Hsc70 (aa 1-554, E213A/D214A) lacking the 10 kDa C-terminal tail. 
Nucleotide-binding domain (NBD) in light grey, linker in black (only visible in B), 
substrate-binding domain (SBD) in blue with residues 539-544 (red) occupying the 
substrate-binding pocket. C) Ribbon structure of the substrate-binding domain of 
DnaK bound to a synthetic peptide (orange). The α-helical 10 kDa tail forms a lid over 
the substrate-binding pocket. D) Model of the Hsc70 ADP/ATP cycle and its 
regulation by co-chaperones CHIP, Hsp40, Hip and nucleotide exchange factor Bag. 
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The three most studied families of co-chaperones are the J-domain family, the 
Bag domain family and tetratricopeptide repeat (TPR) domain containing proteins (80, 
98). The prototype member of the J-domain family is Hsp40 (DnaJ in E. coli) 
whichinteracts with HSP70 proteins via a conserved J-domain and stimulates the 
otherwise low ATPase activity of HSP70s (70). Hsp40 thus promotes the more stable 
binding of substrates in the ADP-bound form. The J-domain is characterized by a His-
Pro-Asp tripeptide which is critical for the co-chaperone’s activity (14). The major 
binding site for J-domains seems to be the ATPase domain of HSP70s (54). There is 
also evidence, though, that the C-terminus of Hsc70 is also involved in Hsp40 binding 
and activity (38). A mutant of Hsc70 lacking only the C-terminal EEVD motif no 
longer interacts with Hsp40 in an in vitro binding assay, but another mutant devoid of 
the full 10 kDa tail still displays stimulated ATPase activity in the presence of Hsp40 
(28). 
Bag-1 is a member of the Bag domain family of nucleotide exchange factor co-
chaperones and also interacts with the ATPase domain of HSP70s. Bag-1 binding to 
HSP70 chaperones facilitates the ADP-ATP exchange and thus the release of bound 
substrate and recycling of HSP70 proteins (46). Hop, Hip and CHIP are members of 
the TPR domain-containing co-chaperone family. Hop or Hsp70/Hsp90-organizing 
protein binds both Hsp70 and Hsp90 and coordinates them during progesterone 
receptor complex assembly (19). The Hsc70-interacting protein Hip can in itself 
function as an ATP-independent chaperone, but as the name says, also interacts with 
Hsc70. This interaction is enhanced in the event of Hsp40-stimulated ATP hydrolysis 
by Hsc70. Hip binds the nucleotide-binding domain of Hsc70 and stabilizes the ADP-
bound conformation, thus prolonging the interaction of Hsc70 with its substrate and 
favoring the substrates proper folding (47). CHIP stands for C-terminus of Hsc70-
interacting protein and is another member of the TPR domain containing co-
 16
chaperones. CHIP interacts with the C-terminal 110 amino acids of Hsc70 and has 
been found to counteract the ATPase stimulating effect of Hsp40 (4). Thereby, this co-
chaperone actually prevents the formation of stable chaperone-substrate complexes 
and hinders protein folding. CHIP is a unique co-chaperone as it also contains a U-box 
with E3 ubiquitin ligase activity and thus constitutes a link between the chaperone and 
the proteasome system (66). 
 
Chaperones in viral lifecycles 
Many viruses use chaperones in different stages of their lifecycle, such as 
entry, translocation of viral proteins to certain cellular compartments, genome 
replication or assembly of progeny virions (reviewed in reference (64). Hepadnavirus, 
for example, requires heat shock protein 90 (Hsp90) and its partner p23 for reverse 
transcription and RNA packaging (48, 92). The minor capsid protein L2 of 
papillomaviruses is dependent on Hsc70 for its nuclear translocation (35). Other 
viruses choose to encode their own chaperone proteins. African Swine Fever Virus 
produces the chaperone-like CAP80 protein that is necessary for capsid protein folding 
and assembly (23). Similarly, closterovirus encodes a heat shock protein 70 
homologue (Hsp70h) and p61 protein that are essential for efficient virion assembly 
(85). 
SV40, the prototype of the Polyomaviridea family engages chaperones in 
capsid assembly as well as cell transformation. In in vitro assays the capsid proteins 
VP1 and VP3 of SV40 forms capsids that are similar to empty virus particles derived 
from infected cells if the proteins are incubated with Hsc70 and the large T antigen 
(TAg) (21). In vivo, assembly of capsids occurs only in the nucleus, and VP1 and 
Hsc70 have been found to co-localize in the nucleus late in infection (25). Given the 
fact that the large TAg binds the polyomavirus genome and possesses a co-chaperone 
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specific J-domain, the following scenario seems possible (79, 91). Hsc70-bound VP1 
translocates into the nucleus where it is recruited through the interaction of Hsc70 with 
the J-domain of the large TAg to the TAg-bound viral genome. One of the 
mechanisms of cell transformation by the large TAg involves the liberation of cell 
cycle regulatory transcription factor E2F, a process that has also been found to involve 
the association of TAg with Hsc70 via its J-domain (95). 
 
Chaperones in the reovirus lifecycle 
Chaperones have already been found to be involved in some parts of the 
reovirus life cycle. After attachment of the virion to the cell and endocytic uptake, the 
outer capsid protein σ3 is proteolytically removed, leaving behind the ISVP (7, 51). In 
ISVPs, µ1 is cleaved into three µ1 fragments, µ1N and the δ and Φ fragments (17, 76). 
The smaller µ1N and Φ fragments are released from the ISVP during membrane 
penetration, but the δ portion of µ1 remains associated with the ISVP (1, 16, 76). 
Ivanovic et al. showed that the release of the δ fragment from ISVPs is aided by the 
cellular chaperone Hsc70 (49). 
Another role for chaperones in the reovirus life cycle has been described for 
the folding of the σ1 attachment protein. σ1 resembles a long fiber consisting of a tail 
and head domain (31, 37). In the mature virion one σ1 trimer is located at each of the 
fivefold axis of symmetry (39, 93). The trimerization of σ1 occurs in two distinct 
steps. The N-terminal tail trimerizes cotranslationally and without the aid of 
chaperones (56). However, the C-terminal head domain depends on ATP, Hsp70 and 
Hsp90 in order to post-translationally achieve the proper folding (41, 56). 




In this thesis I present the results of my studies on the interaction of different 
reoviral proteins with the cellular chaperone, heat shock cognate protein 70 (Hsc70). 
Chapter 2, shows how the nonstructural protein µNS of reovirus interacts with Hsc70 
independently of its chaperoning function. Chapter 3 discusses the association of 
Hsc70 with the outer capsid protein µ1, the influence of the chaperone on the 
trafficking of another outer capsid protein, σ3, and the possible implications for µ1:σ3 
complex formation. Chapter 4 explores other potential ways how the functions of µ1 
are regulated during infection and investigates ubiquitination and caspase cleavage of 
µ1. Specific background information pertinent to each chapter will be reviewed in 
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The cellular chaperone Hsc70 is specifically recruited to reovirus viral factories 

























Mammalian orthoreoviruses replicate and assemble in the cytosol of infected 
cells. A viral nonstructural protein, μNS, forms large inclusion-like structures called 
viral factories (VFs) in which assembling viral particles can be identified. Here we 
examined the localization of the cellular chaperone Hsc70 and found that it co-
localizes with VFs in infected cells and also with viral factory-like structures (VFLs) 
formed by ectopically expressed µNS. SiRNA-mediated knockdown of Hsc70 did not 
affect the formation or maintenance of VFLs. We further showed that dominant 
negative mutants of Hsc70 were also recruited to VFLs, indicating that Hsc70 
recruitment to VFLs was independent of chaperoning function. In support of this 
finding μNS was immunoprecipitated with wild type Hsc70, with a dominant negative 
mutant of Hsc70, and with the minimal substrate-binding site of Hsc70 (amino acids 
395-540). We identified the minimal region of µNS sufficient to interact with Hsc70 
between amino acids 222-271, a region of µNS that has not been ascribed any function 
to date. However, point mutants in this region or the complete deletion of this domain 
did not abrogate µNS-Hsc70 interaction, indicating that a second portion of μNS also 
interacts with Hsc70. Taken together these findings suggest a specific chaperone 




Mammalian orthoreoviruses have a genome of ten double-stranded RNA 
(dsRNA) segments that are encased in a double-layered nonenveloped capsid. 
Replication and assembly of reoviruses are thought to take place in distinct 
cytoplasmic inclusion bodies called viral factories (VFs) (32). The matrix of these 
structures is formed by the nonstructural viral protein μNS (5). The factories are not 
static elements, but can fuse with other viral factories in the same infected cell (Parker, 
unpublished findings). During the course of infection other viral proteins are recruited 
to the viral factories at distinct times (2, 8, 27). By thin section electron microscopy 
the matrix of viral factories appears to consist of fibrils that have a distinct kink (9, 10, 
34). However, an atomic resolution structure of μNS is not available. If expressed 
alone without other viral proteins, the 80 kDa μNS protein forms viral factory-like 
(VFL) structures that resemble VFs in infected cells (5). The carboxyl-terminal (C-
terminal) third of μNS comprising amino acids (aa) 471-721 is sufficient for VFL 
formation (2). This minimal factory-forming region has two predicted coiled-coil 
domains linked by a putative zinc hook and followed by a short C-terminal tail (25). 
The first third of μNS (aa 1-221) has been identified as a scaffold for the recruitment 
of the viral proteins λ1, λ2, µ2, σ2, and σNS; in contrast the RNA-dependent RNA 
polymerase (RdRp), λ3, interacts with the C-terminal minimal factory-forming region 
(5, 26, 27). So far no function has been elucidated for the middle portion of μNS (aa 
222-470). 
Many viruses are dependent upon or at least aided during their lifecycle by 
either cellular or virally encoded chaperones (22). Cellular chaperones are involved in 
folding and refolding of proteins, disaggregation of protein aggregates, translocation 
of proteins across membranes and the assembly and disassembly of oligomeric protein 
complexes [reviewed in (38)]. One of the most abundant chaperones in eukaryotic 
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cells is the heat shock cognate protein 70 (Hsc70). In addition, a closely related 
protein, heat shock protein 70 (Hsp70) is induced during cellular stress. Chaperones 
are involved in entry/disassembly of virions, translocation of the viral genome to the 
site of replication, replication itself, packaging of the genome, folding of capsid 
proteins and assembly of capsids (reviewed in (22)). During reovirus entry the outer 
shell of the double-layered particle is first proteolytically processed to remove the 
outer capsid protein σ3. The remaining outer capsid protein μ1 then undergoes 
autoproteolysis and conformational change that allows the particle to penetrate into the 
cytosol. Following entry of this subviral particle into the cytosol of cells the δ 
fragment of μ1 remains associated with the viral core particle (reviewed in (11)). This 
δ fragment of μ1 is removed from core particles in a process dependent upon Hsc70 
(18). Furthermore, folding of the σ1 attachment protein is dependent on Hsp70 and 
Hsp90 (16, 20). 
Here we show that the cellular chaperone Hsc70 specifically interacts with the 
VF matrix protein μNS. 
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Materials and Methods 
Cells and viruses. CV-1 cells were grown at 37°C in 5% CO2 in Eagles 
Minimum Essential Medium (MEM) (CellGro) supplemented with 10% fetal bovine 
serum (HyClone), 100 U ml-1 of penicillin, 100 µg ml-1 streptomycin, 250 ng ml-1 
amphotericin B, 50 µg ml-1 gentamycin, 125 ng ml-1 amphotericin B (antibiotic-
antimycotic solution, Cellgro) and non-essential amino acids (CellGro). 293F (human 
embryonic kidney cells) cells were grown on a shaker (125 rpm) at 37°C in 8% CO2 in 
FreeStyle™ 293 Expression Medium (Gibco) supplemented with 50 U ml-1 penicillin, 
50 µg ml-1 streptomycin and 125 ng ml-1 amphotericin B (antibiotic-antimycotic 
solution, Cellgro). Reoviruses T1L and T3D were laboratory stocks of the isolates 
previously identified as T1/human/Ohio/Lang/1953 and 
T3/human/Ohio/Dearing/1955, respectively (17). The superscript N in T3DN 
differentiates a laboratory stock obtained from the Nibert laboratory from a T3D clone 
obtained from L. W. Cashdollar (Medical College of Wisconsin), denoted T3DCD. The 
T3DCD clone differs from the T3DN clone in viral factory morphology and in the 
nucleotide sequence of its M1 genome segment (31). Viruses were plaque-purified and 
amplified in murine L929 cells in Joklik's modified minimal essential medium (Gibco) 
supplemented with 4% fetal bovine serum (HyClone), 2 mM glutamine (Cellgro), 100 
U ml-1 penicillin, 100 µg ml-1 streptomycin, 250 ng ml-1 amphotericin B (antibiotic-
antimycotic solution, Cellgro) and 50 µg ml-1 gentamycin (Cellgro). 
Antibodies and reagents. Rabbit polyclonal antiserum against µNS has been 
described previously (4, 35, 36). Rat monoclonal antibody (mAb) against Hsc70 (1B5; 
not cross-reactive with Hsp70) immunoglobulin G (IgG) isotype 2a (IgG2a) was 
purchased from Stressgen and rat mAB anti-HA (3F10) IgG1 antibody was obtained 
from Roche Diagnostics (Mannheim, Germany). A rat mAb IgG2a against Trichinella 
spiralis 18H1.1 (Tsp) was a kind gift from Dr. Judith Appleton. Mouse mAb against α-
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tubulin (DM1A) was purchased from Sigma Aldrich. Rabbit pAb against the 
HaloTag7 was purchased from Promega. Secondary antibodies for 
immunofluorescence (IF) microscopy were goat anti-mouse IgG, goat anti-rabbit IgG, 
and goat anti-rat IgG conjugated to Alexa 488 or Alexa 594 (Invitrogen). Secondary 
antibodies for immunoblot detection were donkey anti-rabbit IgG, donkey anti-mouse 
IgG, and rabbit anti-rat IgG conjugated to horseradish peroxidase (HRP) (Jackson 
ImmunoResearch). Secondary antibodies used with the Odyssey Infrared Scanner (LI-
COR) were IRDye 800CW goat anti-mouse IgG and IRDye 680 goat anti-rat IgG (LI-
COR). All antibodies were titrated to optimize signal to noise ratios. 
Plasmid construction. Plasmid pCI-M3(T1L) has been described previously 
(4). The gene encoding bovine Hsc70 was PCR-amplified using pEGFP-Hsc70 
(courtesy of S. Schmid) as template. The PCR product was purified and cut with XhoI 
and NheI restriction enzymes (NEB Biolabs) then ligated into pCI-neo cut with the 
same enzymes. Dominant negative mutants K71M, D199S and T204V of Hsc70 were 
cloned similarly from their pEGFP background into pCI-neo. Wild type and mutant 
Hsc70 were tagged at the C-terminus with an HA-tag by Phusion PCR. pFN21A-
HaloTag7-Flexi and HaloTag control vectors were purchased from Promega. Various 
truncation and/or point mutants of pCI-Hsc70-HA, pCI-M3(T1L) and pFN21A-
HaloTag7-M3(T1L) were constructed using standard mutagenesis. The following 
twenty point mutants of μNS were prepared: H223A, G229A, D232A, E234A, 
Y236A, N237A, R240A, M242A, F243A, Q245A, H246A, P248A, L249A, Q253A, 
Y255A, D262A, Y263A, F264A, P268A, and D271A. Cloning details and primers 
available upon request. 
Infections and transfections. CV-1 cells were seeded the day before 
transfection or infection at a density of 5 × 104  in twelve-well plates containing 18-
mm-diameter round glass cover slips. Infections were begun by adsorbing virus stocks 
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to cells at an MOI of 5 PFU/cell or as indicated, for 1 h at room temperature in 
phosphate-buffered saline (PBS) (137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4, 1 mM 
KH2PO4 [pH 7.5]). Cells were then overlaid with growth medium and incubated at 
37°C for 24 h or as indicated. CV-1 cells were transfected using FuGene HD 
transfection reagent (Roche) according to the manufacturer’s instructions. A 7:2 ratio 
of FuGene HD reagent to DNA was used. Transfected cells were incubated at 37°C 
for 24 h or as indicated. 293F cells were transfected using 293fectin (Invitrogen) 
according to the manufacturer’s instructions. The day before transfection 293F cells 
were set up at a density of 5-7 × 105 per ml in 14 or 28 ml of antibiotic-free 
FreeStyle™ 293 Expression Medium. A 2:1 ratio of 293fectin to DNA was used. 
siRNA treatment. For IF studies CV-1 cells were seeded the day before 
transfection at a density of 1.5 × 104 in twelve- well plates containing 18-mm-diameter 
round cover slips. Cells were transfected with 100 nM siRNA J-017609-08 
(Dharmacon) using Dharmafect 1 transfection reagent (Dharmacon) according to the 
manufacturer’s instructions. The complexes were incubated for 20 min then added to 
cells and incubated at 37°C for the indicated amount of time. 
To evaluate the knockdown efficiency, CV-1 cells were seeded the day before 
transfection at a density of 5 × 104 in six-well plates and transfected as above with 
either Hsc70 siRNA or non-specific control siRNA. Cells were harvested 48, 72 and 
96 h after transfection by trypsinization. Pellets were lysed in 30 µl of 10% SDS and 
31.2 mM Tris-HCl pH 7.4 then sonicated with a microtip (power 2, duty cycle 20%, 2 
× 10 times on ice). Total protein concentration of the lysates was determined (DC 
Protein Assay; BioRad) and equal amounts were analyzed by SDS-PAGE and 
immunoblotting. Simultaneous detection of Hsc70 and α-tubulin was performed with 
the Odyssey Infrared Scanner (LI-COR) utilizing primary antibodies rat anti-Hsc70 
and mouse anti-α-tubulin followed by secondary antibodies IRDye 680 goat anti-rat 
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IgG and IRDye 800CW goat anti-mouse IgG. The integrated intensity of the selected 
Hsc70 and α-tubulin bands was measured by the Odyssey program and the relative 
amount of Hsc70 was normalized to the amount of α-tubulin. Data from three 
independent experiments were collected and differences in the means were evaluated 
by a paired one-tailed Student’s t-test. 
Immunofluorescence (IF) microscopy. Cells on glass cover slips were fixed 
for 10 min at room temperature in 2% paraformaldehyde in PBS, washed 3 times in 
PBS, then permeabilized for 15 min in PBS containing 1% bovine serum albumin 
(BSA), 0.1% Triton X-100 and 0.05% sodium azide (PBSA-T). Where indicated, cells 
were fixed with 100% methanol for 20 seconds at -20°C and then rehydrated by 
washing 3 × 5 min in PBSA-T. All antibody incubations were carried out for 30 min at 
room temperature in PBSA-T. Cover slips were washed 3 times in PBS between 
primary and secondary antibody incubations. Cover slips were mounted on glass slides 
with ProLong Gold + DAPI reagent (Molecular Probes). Fluorescence and phase 
images were obtained with a Nikon TE2000 inverted microscope equipped with 
fluorescence and phase optics through a 60 × 1.4 NA oil objective with 1.5 × optical 
zoom. Images were collected digitally with a Coolsnap HQ CCD camera (Roper) and 
Openlab software (Improvision) then were prepared for publication using Photoshop 
and Illustrator software (Adobe Systems). 
Immunoprecipitation (IP) and immunoblotting. 293F cells were harvested 
by centrifuging the cell suspension for 5 min at 500 × g and 4°C. Cells were washed 
twice with cold PBS and lysed in 1 ml lysis buffer (50 mM Tris-HCl pH 7.4, 100 mM 
NaCl, 1% Tween-20, 1 mM phenylmethylsulfonylfluoride) on ice for 30 min. Lysates 
were cleared by centrifuging for 15 min at 16,060 × g and 4°C. For each sample 2.5 
µg of anti-Trichinella spiralis (anti-Tsp) or anti-Hsc70 antibody was bound to 30 µl of 
recombinant protein G agarose (Invitrogen) by rotating for 1 h at room temperature in 
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500 µl PBS with 0.5 µl of 10% Triton X-100. Afterwards the antibody-bound agarose 
was washed 3 times in 1 ml of TBST (Tris buffered saline Tween-20) and incubated 
30 min or overnight at 4°C with the pre-cleared cell lysate. Anti-HA 3F10 antibody 
(and anti-Tsp control antibody) were added unbound together with 30 µl of 
recombinant protein G agarose to the pre-cleared cell lysate at a concentration of 0.25 
µg per sample and incubated as above. Samples were washed 4-6 × 5 min with 1 ml of 
wash buffer (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 2% Tween-20) on ice. After a 
final wash with 1 ml PBS, 5 µl of 5 × sodium dodecyl sulfate (SDS) sample buffer 
was added to each sample and boiled for 5 min at 95°C. Bound proteins were 
separated by SDS polyacrylamide gel electrophoresis (PAGE). Proteins were 
transferred from gels to nitrocellulose membranes and blocked for 30 min at room 
temperature in 1 × PBS (pH 7.4) containing 0.1% Tween-20, 100 U ml-1 penicillin, 
100 µg ml-1 streptomycin and 5% powdered milk. Precipitated proteins were detected 
with rabbit anti-µNS antiserum, rat anti-Hsc70 and rat anti-HA 3F10 antibodies in 
blocking buffer for 1 h at RT or overnight at 4°C. Membranes were washed 3 × 5 min 
in 1 × TBST before incubation with secondary antibodies for 1 h at RT and final 
washes of 6 × 5 min in 1 × TBST. Secondary antibodies used were donkey anti-rabbit, 
donkey anti-mouse and rabbit anti-rat IgG conjugated to horseradish peroxidase 
(HRP) and were detected with SuperSignal West Pico Chemiluminescent Substrate 
(Pierce) and fluorography. For consecutive probing with different antibodies, 
immunoblots were stripped with 10% SDS, 6.25 mM Tris, 143 mM β-
mercaptoethanol, heated to 65°C for 15 min at room temperature, followed by 3 × 5 
min washes in 1 × TBST. 
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Results 
Hsc70 localizes to VFs in infected cells and co-localizes with ectopically-
expressed µNS in VFLs. During immunofluorescence experiments to identify cellular 
proteins that interact with the reovirus outer capsid protein µ1, we noted that the 
constitutively expressed cellular chaperone Hsc70, in addition to localizing with µ1 on 
membranous structures, localized to viral factories (Figure 2.1A; see arrowheads). To 
confirm this observation, we co-stained infected cells with antibodies for Hsc70 and 
μNS. In mock-infected CV-1 cells Hsc70 was distributed diffusely in the cytosol and 
nucleus (data not shown). However, in cells infected with T1L, T3DCD or T3DN 
reovirus we found that Hsc70, also co-localized with μNS in viral factories (Figure 
2.1B; data not shown for T3DCD and T3DN). As several viral proteins localize to VFs, 
we tested if Hsc70 co-localized with VFLs formed by µNS alone. In CV-1 cells 
transfected with a plasmid encoding µNS derived from reovirus strain T1L Hsc70 co-
localized with μNS VFLs (Figure 2.1C). We conclude from these results that the 





Figure 2.1: Hsc70 interacts with the VF matrix protein µNS. A) T3DN- or B) T1L-
infected CV-1 cells were immunostained for A) µ1 and Hsc70 or B) µNS and Hsc70. 
C) CV-1 cells transfected with a µNS-encoding plasmid (pCI-M3 T1L) were 
immunostained for µNS and Hsc70. Arrowheads in A) indicate VFs. Scale bars, 10 
µm. D) IP of µNS by Hsc70 from pCI-M3(T1L)-transfected 293F cells or from E) 
T3DCD-infected L929 cells (IB, immunoblot). anti-Tsp anti-Trichinella spiralis control 
antibody. Volume of lysate loaded corresponds to 1% of volume used in IP. 
 
µNS co-immunoprecipitates with Hsc70 in infected cells and in cells 
ectopically expressing μNS. Having found that Hsc70 and µNS co-localized in VFLs, 
we determined if the two proteins interacted by immunoprecipitating endogenous 
Hsc70 from 293F cells ectopically expressing µNS. Immunoblots probed with anti-
µNS antiserum revealed that μNS co-immunoprecipitated with Hsc70, while a control 
antibody did not precipitate µNS or Hsc70 (Figure 2.1D). To confirm that this 
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interaction also occurred in infected cells, we immunoprecipitated Hsc70 from T3DN-
infected cells and similarly found that μNS co-precipitated with anti-Hsc70 antibody, 
but not with control antibody (Figure 2.1E). Based on these findings we conclude that 
Hsc70 and µNS interact. 
Formation and maintenance of VFLs is not impaired by siRNA 
knockdown of Hsc70. The matrix of VFs is believed to form by oligomerization of 
µNS, a process that might require the assistance of chaperones. Given the interaction 
of Hsc70 and µNS, we tested the possibility that Hsc70 was required for the formation 
and/or maintenance of VFLs, as Hsc70 chaperones aid in the oligomerization of some 
proteins (23). To test this hypothesis, we depleted Hsc70 from CV-1 cells using small 
interfering RNA (siRNA) and then transfected the cells with a plasmid encoding μNS. 
We measured the efficiency of depletion of Hsc70 by immunoblot and detection by 
infrared scanning and found that after treatment with Hsc70 siRNA 68%, 87%, and 
96% of Hsc70 was depleted at 48, 72, and 96 h post-treatment, respectively (Figure 
2.2A). To evaluate the role of Hsc70 in the initial formation of VFLs, cells were 
treated with Hsc70 or control siRNAs and then transfected with a µNS-encoding 
plasmid 24, 48 or 72 h post siRNA. In this way µNS was introduced into a cellular 
environment with less and less Hsc70 present. At the last transfection time point, when 
only 13% of Hsc70 was available, we detected VFLs that were indistinguishable from 
VFLs formed in control siRNA treated cells (Figure 2.2B). 
Viral factories in infected cells are not static in the cytosol, but can divide or 
fuse with other VFs (Parker unpublished observations). Hsc70, if dispensable for the 
initial formation of VFs, could be important for the long term maintenance or 
remodeling of VFs. Therefore, we treated cells with Hsc70 siRNA as before, then 
transfected the cells with a plasmid encoding µNS 24 h later. We then evaluated the 
morphology of VFLs at 48, 72, and 96 h after siRNA (24, 48, and 72 h after µNS 
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transfection). We found that there was no difference in the size, shape or number of 
μNS VFLs between control siRNA-treated and Hsc70 siRNA-treated cells (Figure 
2.2C). Taken together these results suggest depletion of Hsc70 does not affect the 
































Figure 2.2: Depletion of endogenous Hsc70 does not affect the formation or 
maintenance of µNS VFLs. A) siRNA depletion of endogenous Hsc70. IF images of 
CV-1 cells stained for Hsc70 at 48, 72, and 96 h after treatment with control or Hsc70 
siRNAs . The efficiency of Hsc70 depletion was quantified by immunoblot (a 
representative immunoblot is shown top right; quantitation is shown below). CV-1 
cells were treated with control (-) or Hsc70 siRNA (+) for 48, 72 or 96 h. Bars show 
mean ± SD of three independent experiments. Statistically significant differences 
between control- and Hsc70 siRNA-treated cells are indicated, one-tailed Student’s t-
test. * p < 0.05, ** p < 0.001. B) siRNA depletion of Hsc70 does not affect the B) 
formation or maintenance C) of µNS VFLs. IF images of CV-1 cells treated with 
control (con) or Hsc70 siRNA (si) for 48, 72 or 96 h and then transfected with pCI-
M3(T1L) as diagrammed in the schematics above the IF panels. Cells were fixed and 












Dominant negative mutants of Hsc70 still co-localize with µNS. To further 
investigate how Hsc70 was recruited by µNS, we examined the capacity of different 
dominant negative mutants of Hsc70 to be recruited to µNS VFLs. Dominant negative 
mutants of Hsc70 have a mutation in their nucleotide binding site that affects the ATP-
ADP-cycle of the chaperone (28). The ATPase rate of Hsc70-K71M is undetectable, 
while it is reduced 50-fold in Hsc70-D199S. These two mutants are predominantly 
ATP-bound and they bind and release substrate rapidly (29, 37). A third mutant, 
Hsc70-T204V, has normal ATP-hydrolysis activity, but a 100-fold reduced ATP-
binding activity (30). Thus, Hsc70-T204V is predominantly ADP-bound and binds 
and releases substrate slowly. As anti-Hsc70 antibody cannot distinguish between 
endogenous Hsc70 and mutant Hsc70, the dominant negative mutants were HA-
tagged. When we co-expressed the dominant negative Hsc70 mutants with µNS we 
found that like wild type Hsc70, all the dominant negative mutants co-localized with 
VFLs formed by µNS (Figure 2.3). We conclude from these results that the interaction 




Figure 2.3: Dominant inhibitory mutants of Hsc70 co-localize with µNS VFLs. CV-1 
cells were co-transfected with plasmids expressing µNS and HA-tagged WT or the 
indicated DN mutants of Hsc70. Cells were fixed and immunostained for µNS and the 
HA tag 24 h post-transfection. Scale bars, 10 µm. 
 
Mapping of the minimal region of Hsc70 required for interaction with 
μNS. The co-localization of the dominant negative mutants of Hsc70 with µNS VFLs 
suggested that the interaction of Hsc70 with μNS was independent of Hsc70 
chaperone function. Therefore, to identify the region of Hsc70 that interacted with 
μNS, we constructed C-terminally HA-tagged truncation mutants of Hsc70 that 
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comprised either the N-terminal ATPase domain (aa 1-394), including the interdomain 
linker (aa 384-394) or the C-terminal substrate-binding domain (SBD; aa 395-650) 
(19) (Figure 2.4A). As a control, we also tested an HA-tagged version of the VP1 
protein of feline calicivirus, which is not known to interact with µNS. We co-
expressed each of the truncated Hsc70 domains with µNS and immunoprecipitated the 
HA-tagged Hsc70 domains with an anti-HA antibody. Immunoblots showed that μNS 
co-immunoprecipitated with the SBD (aa 395-650), but not the ATPase domain of 
Hsc70 (Figure 2.4B). As expected μNS did not co-immunoprecipitate with the VP1-
HA control protein (data not shown). 
The SBD of Hsc70 can be subdivided into the substrate-binding site, which 
consists of β-sheets connected by loops and an α-helical 10 kDa C-terminal tail 
(Figure 2.4A). The C-terminal tail of Hsc70 is not involved in substrate binding but 
has been found to interact with different co-chaperones via distinct interaction motifs 
(13, 21). The EEVD motif at the very C-terminus of Hsc70 is necessary for Hsc70 
interaction with Hsp40 co-chaperones (14). Another co-chaperone interaction domain 
is comprised of an α-helical domain and multiple degenerate repeats of the 
tetrapeptide GGMP (1). To define the interacting region of the SBD of Hsc70 for 
µNS, we created: i) a mutant of the SBD that was truncated at aa 540 and thus only 
contained the minimal substrate-binding site, ii) a truncation comprising aa 395-560 
which includes the first α-helix of the α-helical domain, iii) a mutant that lacks the 
GGXP repeats and the EEVD motif (aa 395-614), and iv) the SBD without the C-
terminal EEVD motif (aa 395-646) (Figure 2.4A). When these mutants were co-
expressed with µNS, we found that the constructs 395-540, 395-614 and 395-646 
interacted with µNS (Figure 2.4C). We confirmed that the minimal region of Hsc70 
(aa 395-540) localized to VFLs by co-expressing this construct with μNS in CV-1 
cells (Figure 2.4D, bottom panels). In agreement with our IP findings, the ATPase 
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domain of Hsc70 (aa 1-394) did not colocalize with μNS VFLs (Figure 2.4D, top 
panels). Although, we were unable to show that immunoprecipitation of HA-tagged 
Hsc70 (395-560) pulled down µNS (Figure 2.4C), this mutant co-localized with µNS 
VFLs (data not shown) suggesting that the interaction in vitro may be sterically 
hindered. Taken together, these results indicate that the GGMP tetrapeptide repeats 
and the EEVD motif are dispensable for interaction of Hsc70 with µNS and that µNS 





























Figure 2.4: The ATPase domain of Hsc70 is not required for its interaction with µNS. 
A) Diagram of Hsc70 subdomains and truncation mutants (SBD = substrate binding 
domain). B) 293F cells were co-transfected with the µNS-encoding plasmid and either 
the HA-tagged ATPase or SBD of Hsc70. HA-tagged constructs were 
immunoprecipitated from cell lysates with an anti-HA mAb then immunoblotted (IB) 
and probed for the HA tag or µNS antibody. A control antibody (anti-Tsp) did not 
immunoprecipitate the tagged Hsc70 or µNS. C) 293F cells were co-transfected with 
plasmids encoding µNS and the HA-tagged truncation mutants of Hsc70 depicted in 
A). Immunoprecipitates were prepared and immunoblotted as in B). Volume of lysate 
loaded corresponds to 1% of volume used in IP. D) IF images of cells ectopically 
expressing µNS and Hsc70 (1-394) (top panels) or µNS and Hsc70 (395-540) (bottom 













Mapping of the minimal necessary µNS interaction domain. Our 
knockdown experiments suggested that Hsc70 was dispensable for VFL formation. 
VFs are the site of viral replication and assembly. The viral structural proteins (λ1, λ2, 
λ3, μ1, μ2, σ2, and σ3), and nonstructural protein σNS are recruited to VFs in 
infected cells (3, 5, 8, 27, 33). In cells ectopically expressing μNS, the λ1, λ2, λ3, μ2, 
σ2 and σNS proteins are recruited to VFLs independently of each other (3, 26, 27). 
Therefore, it is possible that Hsc70 plays a role within VFs in preventing aggregation 
of partially folded viral proteins prior to their assembly. Alternatively, Hsc70 may 
play a role in virion assembly or replication. To identify the minimal region of μNS 
necessary for its interaction with Hsc70, we prepared different µNS truncation mutants 
and tested their capacity to co-immunoprecipitate with full-length Hsc70. In contrast 
to full-length μNS, the minimal region of μNS necessary to form VFLs (aa 471-721) 
(2) did not interact with Hsc70 (Figure 2.5A). This result supported our finding that 
viral factory formation occurred independently of Hsc70 and indicated that the region 
encompassing the N-terminal 470 amino acids of µNS interacts with Hsc70. 
The first 221 aa of µNS serve as a scaffold to recruit several of the reoviral 
structural proteins (3, 5, 26). To determine if Hsc70 interacted with this N-terminal 
region of μNS, we created two truncation mutants comprising aa 1-221 and aa 1-470. 
We found that the longer of these truncation mutants (aa 1-470), but not the shorter (aa 
1-221) co-immunoprecipitated with Hsc70 (Figure 2.5B). As Hsc70 did not interact 
with aa 471-721 of µNS, we inferred that the Hsc70-interacting region of µNS lies 
between amino acids 222-470. 
Hsc70 is often recruited to protein aggregates (24). To ensure that the 
truncation mutants of µNS were not misfolding, we examined immunofluorescence 
images of the expressed proteins for co-localization with polyubiquitin. The 
distribution of μNS(1-470) and μNS(1-221) in transfected cells was diffuse 
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throughout the cytosol and we did not see aggregates that co-localized with 
polyubiquitin (data not shown). In addition we found that a co-expressed HA-tagged 
dominant negative form of Hsc70 (T204V) and the SBD of Hsc70 immunoprecipitated 
μNS (1-470) and WT µNS (1-721) (Figure 2.5C). A small amount of full-length μNS 
was non-specifically pulled down by the control antibody, but this was not a consistent 
finding (compare Figure 2.5B with Figure 2.5C). These results suggest that the 
interaction of Hsc70 with the µNS fragment was not due to misfolding of the µNS 
fragment and did not require functional chaperone activity. 
To further narrow down the minimal domain of µNS necessary for interaction 
with Hsc70, we prepared additional truncation mutants of µNS, 1-271, 1-301, 1-341, 
1-381, 1-396 and 1-431. To reduce the risk that the truncated proteins would misfold, 
the truncations were placed in predicted hydrophilic locations of the primary sequence 
of µNS. Although we had already established that the N-terminal 221 amino acids of 
µNS did not interact with Hsc70, we included this portion of the protein in the new 
mutants in order to maintain proper N-terminal folding. After co-IP using an anti-
Hsc70 antibody, we found that all six truncation mutants were able to bind Hsc70, 
suggesting that the minimal region of µNS necessary to interact with Hsc70 lies 


















Figure 2.5: The region of µNS that interacts with Hsc70 lies between aa 222-271. A) 
293F cells were transfected with a plasmid encoding full length µNS (aa 1-721) or the 
minimal factory-forming region of µNS (aa 471-721). Cell lysates were prepared and 
immunoprecipitated with control anti-Tsp or anti-Hsc70 antibodies. Immunoblots 
were then probed for µNS or Hsc70 as indicated. The bottom panel on the left shows a 
longer exposure of the area above. B) Hsc70 in lysates from 293F cells ectopically 
expressing full length µNS or the indicated truncations of µNS was 
immunoprecipitated as described above and the immunoblots were then probed for 
µNS and Hsc70. C) 293F cells were co-transfected with full length µNS (1-721) or 
µNS (1-470) together with HA-tagged SBD (aa 395-650) of Hsc70 or Hsc70 (T204V) 
(DN). An anti-HA mAb was used to immunoprecipitate the HA-tagged Hsc70 
constructs and immunoblots were probed for co-precipitation of µNS. The blot to the 
right at the top shows a longer exposure of the higher molecular weight bands outlined 
in the dotted box in the blot probed with anti-HA. Volume of lysate loaded 
















Mapping of the minimal region of µNS sufficient to interact with Hsc70. 
To determine if aa 222-271 of µNS were sufficient to recruit Hsc70 to the viral 
factories, we prepared HA-tagged µNS truncation mutants that lacked the N-terminal 
221 amino acids resulting in fragments starting at aa 222 and ending at aa 271, 301, 
341, 381, 396 or 431. Unfortunately, none of these constructs was expressed at 
detectable levels (data not shown). We hypothesized that the loss of the natural N-
terminus led to misfolding and rapid degradation of the µNS fragments. 
Because the HA-tagged μNS fragments were not expressed, we tagged the 
constructs at their N-terminus with a larger soluble protein tag, HaloTag, that is 
derived from bacterial hydrolase in the hope that it might stabilize the μNS fragments 
and allow their proper folding. We prepared the truncations described above plus an 
additional truncation mutant comprising aa 222-470. All of the constructs bearing the 
N-terminal HaloTag were expressed at detectable levels. We, therefore, co-expressed 
the constructs with the HA-tagged SBD of Hsc70 (aa 395-650) and 
immunoprecipitated using an anti-HA antibody. We found that all of the tested 
HaloTagged µNS fragments interacted with the SBD of Hsc70. However, the HaloTag 
protein expressed alone did not interact with the Hsc70 SBD (Figure 2.6B). We 
concluded from this finding that aa 222-271 of µNS are sufficient for interaction with 
the SBD of Hsc70. We also tested if the minimal region of µNS that interacted with 
full length Hsc70 was capable of interacting with the minimal interaction domain of 
Hsc70. We co-expressed HaloTagged µNS (aa 222-271) or the HaloTag protein alone 
together with the HA-tagged substrate-binding site (aa 395-540) or SBD (aa 395-650) 
of Hsc70 and immunoprecipitated using an anti-HA antibody. We found that the µNS 
fragment was co-immunoprecipitated (Figure 2.6C) and thus deduced that the 
identified minimal interaction domains in µNS and Hsc70 are sufficient for interaction 










Figure 2.6: Amino acids 221-271 of µNS interact with Hsc70. A) 293F cells were 
transfected with plasmids encoding the indicated C-terminal truncations of µNS. Cell 
lysates were prepared 24 h post-transfection and Hsc70 was immunoprecipitated with 
anti-Hsc70 antibodies. Immunoblots were then probed for µNS or Hsc70 as indicated. 
1-721 denotes full length µNS. Numbers indicate the amino acids of µNS in the 
truncation mutant. B) 293F cells were co-transfected with plasmids encoding the HA-
tagged SBD of Hsc70 (aa 395-650) together with the indicated Halo-tagged fragments 
of µNS. Numbers below indicate the amino acids of µNS in the construct. HA-tagged 
proteins were immunoprecipitated from cell lysates then immunoblotted and probed 
with anti-HaloTag and anti-HA antibodies. C) 293F cells were co-transfected with 
plasmids encoding Halo-tagged µNS(222-271) or the HaloTag Vector alone (Halo) 
together with HA-tagged Hsc70 (395-540) or Hsc70 (395-650; SBD). HA-tagged 
proteins were immunoprecipitated from cell lysates then immunoblotted and probed 
with anti-HaloTag and anti-HA antibodies. Volume of lysate loaded corresponds to 















Point mutants in µNS in the region between amino acids 222-271 fail to 
disrupt the μNS-Hsc70 interaction. Having identified the region between amino 
acids 222 and 271 of μNS as sufficient for interacting with Hsc70, we prepared twenty 
point mutants (see Materials and Methods) within this region to identify individual 
residues important for the µNS-Hsc70 interaction. We chose these mutations based on 
the predicted secondary structure of this region of μNS (Jpred, APSSP, CFSSP, 
NetSurfP) and residue conservation with other homologous reovirus proteins (the 
Muscovy duck reovirus µC protein, Avian orthoreovirus µNS protein, and the 
American grass carp reovirus NS73 protein; the μNS protein is not homologous to any 
protein other than other reoviral proteins). We prepared several mutations within two 
predicted α-helices spanning aa 235-243 and aa 261-266 and analyzed the capacity of 
the mutants to form VFLs by immunofluorescence. Three mutants, F243A, H246A 
and Y263A differed from WT μNS by being unable to form large VFLs and instead 
forming many, very small, pinpoint-like structures in transfected cells (data not 
shown). Co-staining for polyubiquitin revealed that these structures co-localized with 
ubiquitin indicating that these three point mutants were likely misfolding and 
aggregating. The other mutants formed VFLs comparable to those formed by wild-
type µNS and did not co-localize with ubiquitin (an example μNS(D271A) is shown in 
Figure 2.7A). All of the mutants co-immunoprecipitated with Hsc70 (data not shown). 
From these results we concluded that either single point mutants were insufficient to 









Figure 2.7: A deletion mutant of µNS lacking the minimal interaction domain (aa 222-
271) still interacts with Hsc70. A) Immunofluorescence images showing the 
distribution of the µNS(D271A) point mutant (left) and the µNS(Δ222-271) mutant 
(right). CV-1 cells were fixed and immunostained for µNS at 24 h post-transfection. 
Scale bars, 10 µm. B) 293F cells were transfected with plasmids encoding µNS(Δ222-
271) (del) or full-length µNS (M3). Hsc70 was immunoprecipitated from cell lysates 
and immunoblotted and probed with anti-Hsc70 and anti-µNS antibodies. C) 293F 
cells were co-transfected with plasmids encoding µNS(Δ222-271) (del) or full-length 
µNS (M3) together with the HA-tagged SBD of Hsc70 (Hsc70-395-650-HA). HA-
tagged proteins were immunoprecipitated from cell lysates then immunoblotted and 
probed with anti-HA and anti-µNS antibodies. Volume of lysate loaded corresponds to 
1% of volume used in IP. 
 
Deletion of residues 222-271 from µNS does not abrogate its capacity to 
interact with Hsc70. To test the hypothesis that an additional region of μNS 
interacted with Hsc70 we prepared a deletion mutant of μNS lacking aa 222-271 - 
μNS(Δ222-271). This deletion mutant was unable to form VFLs at 24 h post-
transfection. Instead it was diffusely distributed in most transfected cells, occasionally 
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forming aggregates (Figure 2.7A) that co-localized with polyubiquitin (data not 
shown). This deletion mutant co-immunoprecipitated with full length Hsc70 (Figure 
2.7B). This interaction was not likely due to misfolding of the protein, as we found 
that it also interacted with the SBD of Hsc70 that lacks chaperoning function (Figure 
2.7C). Taken together these findings suggest that the initially defined minimal 
interaction domain lying between aa 222-271 of µNS is not the only region of μNS 
that interacts with Hsc70 and that an additional region of μNS between aa 272-470 
likely interacts with Hsc70. 
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Discussion 
Chaperones are required for the efficient replication of many viruses. The E. 
coli HSP70 homolog DnaK protein was discovered as an essential bacterial factor for 
replication of the bacteriophage λ (15). Cellular or viral chaperones play roles in virus 
entry, translocation of viral proteins to different cellular compartments, genome 
replication or assembly and morphogenesis of progeny virions (reviewed in (22)). The 
cellular chaperone Hsc70 is thought to be involved in uncoating of reovirus particles 
during virus entry and Hsp70 is required for post-translational folding and assembly of 
the globular portion of the trimeric σ1 attachment protein (16, 18, 20). Our findings in 
this paper indicate that the constitutively expressed Hsc70 is involved in other phases 
of the reovirus lifecycle. Hsc70 was recruited to viral factories via interaction with the 
factory matrix protein μNS. Although, this interaction was mediated by the SBD of 
Hsc70 it likely occurs independently of Hsc70’s chaperoning function as we found 
that μNS coimmunoprecipitated with dominant negative mutants of Hsc70, which also 
co-localized with VFLs. Additional support for the idea that μNS is not a substrate for 
Hsc70 was our finding that knockdown of Hsc70 did not influence the size or 
morphology of VFLs or their maintenance. Despite these findings, it remains possible 
that μNS is a substrate for Hsc70. Knockdown of Hsc70 was not complete and we 
have found that the inducible form of Hsc70, Hsp70 is also recruited to viral factories 
(unpublished data). Based on these findings we cannot rule out the possibility that 
μNS is a substrate for Hsc70; however, the co-IP of dominant negative mutants of 
Hsc70 strongly suggests that μNS serves as a spatial anchor to recruit Hsc70. 
The N-terminal third (aa 1-221) of μNS is responsible for recruiting most of 
the viral core proteins (λ1,λ2, μ2, and σ2) (3, 5, 26) and nonstructural protein σNS 
(27), while the C-terminal third (471-721) contains the minimal factory forming 
region and has been shown to recruit the core and the λ3 polymerase (26). In contrast, 
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the middle part of µNS (aa 222-470) has no ascribed function. Our findings here 
indicate that a region between amino acids 222-271 within this portion of μNS serves 
to recruit the Hsc70 chaperone. Although our data clearly show that μNS (aa 222-271) 
is sufficient to recruit Hsc70, when these residues were deleted from the full length 
µNS protein, we still detected an association with Hsc70 that was not likely due to 
misfolding of this mutant suggesting that an additional region of μNS potentially 
between aa 272-470 also interacts with Hsc70. The presence of a second region of 
μNS that interacts with Hsc70 may explain our failure to identify point mutants with 
the region of μNS (aa 222-271) that prevented the interaction. 
Why is Hsc70 recruited to μNS VFLs and VFs in infected cells? The μNS 
protein has been hypothesized to act as a scaffold for recruitment of viral proteins 
required for assembly of new viral particles and replication of the viral genome (3, 
26). To this end it seems possible that chaperones are required to assemble the viral 
structural proteins to form virions. The reovirus virion is a double-shelled particle that 
comprises eight structural proteins (λ1, λ2, λ3, μ1, μ2, σ1, σ2, and σ3). The addition 
of the outer shell of the virion to core particles shuts off transcription and it would 
seem possible that this process is regulated by chaperones to prevent premature 
termination of viral transcription. We have found that the μ1 and σ3 heterohexameric 
complexes are associated with Hsc70 (Kaufer and Parker, unpublished findings). 
Chaperones have also been shown to be involved in genome replication for several 
viruses (6, 7). It is also possible that Hsc70 is involved in assortment of genome 
segments for packaging into assembling viral core particles. 
Another possible reason for recruitment of the Hsc70 chaperone is to aid in the 
oligomerization or de-oligomerization of µNS itself. In vitro experiments indicate that 
viral cores readily associate with purified µNS; however, the presence of μNS on viral 
cores inhibits the assembly of outer capsid proteins. Therefore, another possible 
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function for Hsc70 chaperones would be to remove μNS from core particles to allow 
assembly of the outer-capsid proteins to form infectious virions. We found that Hsc70 
is capable of interacting with a non-oligomerized form of µNS, namely a point mutant 
(H570Q) that does not form viral factories but is diffusely distributed in cells 
(unpublished findings). 
A mutant of µNS in which the region between aa 222-271 was deleted formed 
VFLs. However, these VFLs were small in comparison to those derived from WT 
μNS protein. This observation suggests that the region between aa 222-271 of µNS is 
important for formation of larger VFLs. If and how Hsc70 binding to µNS and factory 
formation are connected remains to be elucidated. Our experiments with siRNA 
mediated knockdown of Hsc70 did not reveal any detectable effect of the absence of 
Hsc70 on VFL formation. However, given that there are six highly homologues 
isoforms of HSP70 family members found in the cytosol, one or more of these could 
also be recruited to VFLs and compensate for the loss of Hsc70 in these experiments 
(12). 
In summary, we have defined a region of μNS that specifically interacts with 
the constitutively expressed cellular chaperone Hsc70. Future experiments will define 
the function of this chaperone in reovirus replication. 
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Implications of the interaction of cellular chaperone Hsc70 with reovirus protein 
µ1 for recruitment of the µ1:σ3 heterohexamer to viral factories 
 68
Abstract 
Mammalian orthoreoviruses (reoviruses) are non-enveloped viruses that 
replicate and assemble in the cytosol of infected cells within inclusion-like structures 
called viral factories (VFs). The matrix of VFs is composed of reovirus non-structural 
protein μNS which forms viral factory-like structures (VFLs) if expressed ectopically. 
Here we examined the subcellular distribution of the major outer capsid proteins μ1 
and σ3 in respect to µNS. We found in transfected and infected cells that µ1 depended 
on σ3 for recruitment to VFLs and VFs. This finding suggested that µ1 and σ3 are 
recruited as a complex. We further discovered by immunoprecipitation that the 
cellular chaperone Hsc70 interacted with µ1 and the µ1:σ3 complex. Over-expression 
of Hsc70 increased the frequency of σ3 localization to VFLs. Hsc70 also co-localized 
with µ1 on lipid droplets. Dominant negative forms of Hsc70 did not co-localize with 
µ1, indicating that the µ1-Hsc70 association is dependent on Hsc70 chaperone 
function. siRNA-mediated knockdown of Hsc70, however, had no effect on µ1 
localization to lipid droplets. Taken together these findings suggest a role for Hsc70 in 




Mammalian orthoreoviruses (reoviruses) possess a genome of ten segments of 
double-stranded RNA (dsRNA) enclosed in a non-enveloped double-layered capsid. 
Reovirus replicates in the cytosol of infected cells. Replication is believed to occur 
within inclusion-like structures called viral factories (VFs) (29). The matrix of the VFs 
is formed by the viral non-structural protein μNS (4). If µNS is expressed ectopically, 
it forms viral factory-like structures (VFLs) that resemble the VFs seen in infected 
cells (4). µNS recruits the viral structural proteins that constitute the core particle, λ1, 
λ2, λ3, µ2 and σ2, as well as the non-structural protein σNS (2, 20, 21). All these 
proteins localize to viral factories from early time points in infection and also co-
localize with VFLs if expressed individually with µNS (1, 2, 6, 19, 21). In order to 
generate full virions, cores need to acquire the outer capsid layer consisting mainly of 
µ1 and σ3. Coffey et al found that µ1 exhibits different localization patterns during the 
course of infection, being initially diffusely distributed in the cytosol and associating 
later (12 h -18 h pi) with membranous structures and viral factories (10). The σ3 
protein shows no specific localization besides recruitment to VFs and is diffusely 
distributed in the cytosol and nucleus (33). It is unknown how µ1 and σ3 are recruited 
to viral factories and what mechanism governs the delayed translocation of µ1 to VFs. 
µ1 and σ3 form a complex consisting of three copies of each of the two 
proteins. This heterohexamer is the building block for the outer capsid (18). Preformed 
µ1:σ3 heterohexamers are able to recoat cores in vitro (8). This finding suggests that 
µ1 and σ3 might be recruited to viral factories in a pre-assembled form. Indeed, co-
expression of µ1, σ3 and µNS revealed that while σ3 can co-localize with µNS on its 
own, µ1 is recruited to VFLs only in the presence of σ3 (9). Similarly, a temperature 
sensitive mutant of σ3 which does not expresses viable σ3 at the restrictive 
temperature shows no µ1 association with viral factories (9) and an accumulation of 
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core-like particles in infected cells (23). When and where the µ1:σ3 heterohexamer 
forms in infected cells is unclear. The heterohexamer consists of a base of an 
intertwined µ1 trimer and three σ3 monomers that decorate that trimer and sit in 
between two adjacent µ1 proteins (Figure 1.2) (18). It seems likely that µ1 exists as 
monomers and trimers, and I speculate that µ1 trimerization might occur on 
membranes. σ3 has been crystallized as a dimer, but given the structure of the 
heterohexamer, must monomerize in order to associate with µ1 (27). Because of the 
extensive conformational rearrangements necessary to assemble the µ1:σ3 
heterohexamer, I hypothesize that cellular chaperones might be needed to facilitate 
these rearrangements. Chaperones are proteins that help other proteins to fold 
properly; they aid in the assembly of multi-subunit complexes and prevent subunit 
aggregation (5, 13, 32). Chaperones bind exposed hydrophobic regions until these are 
buried through folding of the protein or association with a binding partner. Two very 
important cellular chaperones are the heat shock cognate protein 70 (Hsc70) and its 
inducible form, heat shock protein 70 (Hsp70). It is already known that these two 
chaperones are involved in the reovirus lifecycle. Folding of the globular head domain 
of the trimeric σ1 attachment protein is dependent on Hsp70 and Hsp90 (16). 
Additionally, complete removal of the δ fragment of the µ1 outer capsid protein from 
infecting virions is aided by Hsc70 (14). Preliminary data also suggest a role for 
Hsc70 in the recruitment of σ3 to VFLs (9). My other work (chapter 2) shows an 
interaction between Hsc70 and µNS. However, the recruitment of Hsc70 to VFLs does 
not seem to be due to a role of Hsc70 in VFL formation (15). So far the role of 
chaperones in assembly of reovirus has not been fully investigated. 
Here I show that the chaperone Hsc70 interacts with µ1 as well as the µ1:σ3 
heterohexamer and that the co-localization of Hsc70 and µ1 is dependent on 
chaperoning function. 
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Materials and Methods 
Cells and viruses. CV-1 cells were grown at 37°C in 5% CO2 in Eagles 
Minimum Essential Medium (MEM) (CellGro) supplemented with 10% fetal bovine 
serum (HyClone), 100 U ml-1 of penicillin, 100 µg ml-1 streptomycin, 250 ng ml-1 
amphotericin B, 50 µg ml-1 gentamycin, 125 ng ml-1 amphotericin B (antibiotic-
antimycotic solution, Cellgro) and non-essential amino acids (CellGro). 293F cells 
were grown on a shaker at 125 rotations per minute (rpm) at 37°C in 8% CO2 in 
FreeStyle™ 293 Expression Medium (Gibco) supplemented with 50 U ml-1 penicillin, 
50 µg ml-1 streptomycin and 125 ng ml-1 amphotericin B (antibiotic-antimycotic 
solution, Cellgro). Reoviruses T1L and T3D were laboratory stocks of the isolates 
previously identified as T1/human/Ohio/Lang/1953 and 
T3/human/Ohio/Dearing/1955, respectively (12). The superscript N in T3DN 
differentiates a laboratory stock obtained from the Nibert laboratory from a T3D clone 
obtained from L. W. Cashdollar (Medical College of Wisconsin), denoted T3DCD. The 
T3DCD clone differs from the T3DN clone in viral factory morphology and in the 
nucleotide sequence of its M1 genome segment (28). Reovirus tsG453 is a 
temperature-sensitive mutant derived from T3D (34). At the restrictive temperature 
(39°C), tsG453 produces low levels of a mutated σ3 protein (amino acids N16K, 
P138S, M141I, and Q229D are mutated) that misfolds and cannot associate with μ1. 
Viruses were plaque-isolated and amplified in murine L929 cells in Joklik's modified 
minimal essential medium (Gibco) supplemented with 4% fetal bovine serum 
(HyClone), 2 mM glutamine (Cellgro), 100 U ml-1 penicillin, 100 µg ml-1 
streptomycin, 250 ng ml-1 amphotericin B (antibiotic-antimycotic solution, Cellgro) 
and 50 µg ml-1 gentamycin (Cellgro). 
Antibodies and reagents. Mouse monoclonal antibodies (mAbs) against μ1 
(4A3, 8H6, 10F6) and σ3 (5C3), and rabbit polyclonal antisera against T1L virions, 
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μNS and σ3 have been described previously (3, 35, 36). Rat monoclonal antibody 
(mAb) against Hsc70 (1B5) (immunoglobulin G (IgG) isotype 2a (IgG2a)) was 
purchased from Stressgen (Victoria, BC, Canada) and rat mAB anti-HA (3F10) IgG1 
antibody was obtained from Roche Diagnostics (Mannheim, Germany). A rat mAb 
IgG2a against Trichinella spiralis 18H1.1 (Tsp) and a mouse mAB IgG2b against H5N1 
(17A2.1.2) hemagglutinin were kind gifts from Dr. Judith Appleton. Secondary 
antibodies for immunofluorescence (IF) microscopy were goat anti-mouse 
immunoglobulin G (IgG), goat anti-rabbit IgG, and goat anti-rat IgG conjugated to 
Alexa 488, Alexa 594, or Alexa 647 (Invitrogen). Secondary antibodies for 
immunoblot detection were donkey anti-rabbit IgG and rabbit anti-rat IgG conjugated 
to horseradish peroxidase (HRP) (Jackson ImmunoResearch). Secondary antibodies 
used with the Odyssey Infrared Scanner (LI-COR) were IRDye 800CW goat anti-
mouse IgG and IRDye 680 goat anti-rat IgG (LI-COR). All antibodies were titrated to 
optimize signal-to-noise ratios. 
Oil Red O staining was used to visualize lipid droplets. After final antibody 
incubation slides were rinsed in 60% isopropanol and incubated in oil red O working 
solution (stock of 5 mg ml-1 Oil Red O in isopropanol diluted 3:2 in H2O) for 2 min. 
Slides were rinsed in 60% isopropanol, then three times in PBS and once in H2O. 
Plasmid construction. The reovirus M2 and S4 genes from T1L were 
subcloned from plasmids pBKS-M2L and pcDNAI-S4L (7) into the mammalian 
expression vector pCI-neo (Promega) to produce pCI-M2(T1L) and pCI-S4(T1L), 
respectively. Plasmid pCI-M3(T1L) has been described previously (3). 
The gene encoding Hsc70 was PCR-amplified using pEGFP-Hsc70 (courtesy of M. 
Ehrlich) as template. The PCR product was purified and cut with XhoI and NheI 
restriction enzymes (NEB Biolabs) then ligated into pCI-neo cut with the same 
enzymes. Dominant negative mutants K71M, D199S and T204V of Hsc70 were 
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cloned similarly from their pEGFP background into pCI-neo. Wild type and mutant 
Hsc70 were tagged at the C-terminus with an HA-tag by Phusion PCR. Cloning details 
and primers available upon request. 
Infections and transfections. CV-1 cells (5 × 104) were seeded the day before 
transfection or infection in twelve-well plates containing 18-mm-diameter round glass 
cover slips. Infections were begun by adsorbing virus stocks to cells at an MOI of 5 
PFU/cell or as indicated for 1 h at room temperature in phosphate-buffered saline 
(PBS) ) (137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4, 1 mM KH2PO4 [pH 7.5]). Cells 
were then overlaid with growth medium and incubated at 37°C for 24 h or as 
indicated. Cells infected with tsG453 were incubated at 32°C or 39°C as indicated. To 
infect 293F cells, cells were pelleted at 4°C at 500 × g for 5 min and resuspended in 2 
ml media containing the virus inoculum. The suspension was incubated for 1 h at 
room temperature and then brought to a density of 1 × 106 cells per ml and incubated 
for 24 h at 37°C and shaking. For immunoprecipitation approximately 1.5 × 107 293F 
cells per IP sample were used. CV-1 cells were transfected using FuGene HD 
transfection reagent (Roche) according to the manufacturer’s instructions. A 7:2 ratio 
of FuGene HD reagent to DNA was used. Transfected cells were incubated at 37°C 
for 24 h or as indicated. 293F cells were transfected using 293fectin (Invitrogen) 
according to the manufacturer’s instructions. The day before transfection 293F cells 
were set up at a density of 5-7 × 105 cells per ml in 28 ml of antibiotic-free 
FreeStyle™ 293 Expression Medium. A 2:1 ratio of 293fectin to DNA was used. 
siRNA treatment. For IF studies CV-1 cells (1.5 × 104) were seeded the day 
before transfection in twelve- well plates containing 18-mm-diameter round cover 
slips. Cells were transfected with 100 nM siRNA J-017609-08 (Dharmacon) using 
Dharmafect 1 transfection reagent (Dharmacon) according to the manufacturer’s 
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instructions. The complexes were incubated for 20 min then added to cells and 
incubated at 37°C for the indicated amount of time. 
To evaluate the knockdown efficiency, CV-1 cells (5 × 104) were seeded the 
day before transfection in six-well plates and transfected as above with either Hsc70 
siRNA or non-specific control siRNA. Cells were harvested 48 h, 72 h and 96 h after 
transfection by trypsinization. Pellets were lysed in 30 µl of 10% SDS and 31.2 mM 
Tris-HCl pH 7.4 then sonicated with a microtip (power 2, duty cycle 20%, 2 × 10 
times on ice). Total protein concentration of the lysates was determined (DC Protein 
Assay; BioRad) and equal amounts were analyzed by SDS-PAGE and 
immunoblotting. Simultaneous detection of Hsc70 and α-tubulin was performed with 
the Odyssey Infrared Scanner (LI-COR) utilizing primary antibodies rat anti-Hsc70 
and mouse anti-α-tubulin followed by secondary antibodies IRDye 680 goat anti-rat 
IgG and IRDye 800CW goat anti-mouse IgG. The integrated intensity of the selected 
Hsc70 and α-tubulin bands was measured by the Odyssey program and the relative 
amount of Hsc70 was normalized to the amount of α-tubulin. Data from three 
independent experiments were collected and differences in the means were evaluated 
by a paired one-tailed Student’s t-test. 
Immunofluorescence (IF) microscopy. Cells on cover slips were fixed for 10 
min at room temperature in 2% paraformaldehyde in PBS, washed 3 times in PBS, 
then permeabilized for 15 min in PBS containing 1% bovine serum albumin (BSA), 
0.1% Triton X-100 and 0.05% sodium-azide (PBSA-T). All antibody incubations were 
carried out for 30 min at room temperature in PBSA-T. Cover slips were washed 3 
times in PBS between primary and secondary antibody incubations. Cover slips were 
mounted on glass slides with ProLong + DAPI reagent (Molecular Probes). 
Fluorescence and phase images were obtained with a Nikon TE2000 inverted 
microscope equipped with fluorescence and phase optics through a 60 × 1.4 NA oil 
 75
objective with 1.5 × optical zoom. Images were collected digitally with a Coolsnap 
HQ CCD camera (Roper) and Openlab software (Improvision) then were prepared for 
publication using Photoshop and Illustrator software (Adobe Systems). Graphs were 
prepared using Kaleidagraph (Synergy Software). 
Immunoprecipitation (IP) and Immunoblot. 293F cells were harvested by 
centrifugation (5 min at 500 × g, 4°C). Cells were washed twice with cold PBS and 
lysed in 1 ml lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Tween-20, 1 
mM phenylmethylsulfonylfluoride) on ice for 30 min. Lysates were cleared by 
centrifuging for 15 min at 16,060 × g and 4°C. For each sample 5 µg of anti-
Trichinella spiralis or anti-Hsc70 antibody was bound to 30 µl of protein G agarose 
(Invitrogen) by rotating for 1 h at room temperature in 500 µl PBS with 0.5 µl of 10% 
Triton X-100. Afterwards the antibody-bound agarose was washed 3 times in 1 ml of 
TBST (Tris buffered saline Tween-20) and incubated overnight at 4°C with the pre-
cleared cell lysate while rocking. Anti-H5N1, anti-σ3 (5C3) and anti-µ1 (8H6 or 
10F6) antibodies were incubated with cell lysate unbound as above and 30 µl of 
protein G agarose was added to each sample the next day and incubated for 1 h at 4°C 
while rocking. Samples were washed 4-6 × 5 min with 1 ml of wash buffer (50 mM 
Tris-HCl pH 7.4, 100 mM NaCl, 2% Tween-20) on ice. After a final wash with 1 ml 
PBS, 5 µl of 5 × sodium dodecyl sulfate (SDS) sample buffer were added to each 
sample and boiled for 5 min at 95°C. Bound proteins were separated by SDS 
polyacrylamide gel electrophoresis (PAGE). Proteins were transferred from gels to 
nitrocellulose membranes and blocked for 30 min at room temperature in 1 × PBS (pH 
7.4) containing 0.1% Tween-20, 100 U ml-1 penicillin, 100 µg ml-1 streptomycin and 
5% powdered milk. Precipitated proteins were detected with rabbit polyclonal antisera 
against T1L virions (to detect µ1) and σ3 and rat anti-Hsc70 antibody in blocking 
buffer for 1 h at RT or overnight at 4°C. Membranes were washed 3 × 5 min in 1 × 
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TBST before incubation with secondary antibodies for 1 h at RT and final washes of 6 
× 5 min in 1 × TBST. Secondary antibodies used were donkey anti-rabbit and rabbit 
anti-rat IgG conjugated to horseradish peroxidase (HRP) and were detected with 
SuperSignal West Pico Chemiluminescent Substrate (Pierce) and fluorography. For 
consecutive probing with different antibodies, immunoblots were stripped with 10% 
SDS, 6.25 mM Tris, 143 mM β-mercaptoethanol, heated to 65°C for 15 min at room 
temperature, followed by 3 × 5 min washes in 1 × TBST. 
 77
Results 
Previous work in our lab addressed questions concerning the subcellular 
localization and trafficking of the outer capsid proteins µ1 and σ3. The findings have 
been published in Dr. Caroline Coffey’s thesis (9) and will be partially recapitulated 
here in order to aid the understanding of my new data presented here. Coffey showed 
that the viral proteins μ1, σ3, and μNS exhibit distinct localization patterns when 
expressed individually in cells: μ1 localized predominantly to lipid droplets, the 
endoplasmic reticulum and mitochondria, σ3 localized to the nucleus and cytosol and 
μNS formed globular VFLs (Figure 3.1A). Co-expression experiments revealed the 
inability of µ1 to co-localize with µNS VFLs, while σ3 was able to co-localize with 
VFLs (Figure 3.1B). Further experiments with triply transfected cells (µ1, σ3 and 
µNS) showed that µ1 was only recruited to VFLs in the presence of σ3 (Figure 3.2A). 
This finding was corroborated using a temperature sensitive mutant of σ3. At the 
restrictive temperature the tsG453 strain does not produce viable σ3 protein and µ1 
was no longer recruited to VFs (Figure 3.2B). Coffey also proposed a role for the 
cellular chaperone Hsc70 in outer capsid trafficking to VFs based on her finding that 
over-expression of Hsc70 increased the frequency of σ3 localization to VFLs in 














Figure 3.1: Subcellular distribution of µ1, σ3 and µNS expressed individually or in 
combination. The images were prepared by Caroline Coffey and reassembled into this 
figure (9). CV-1 cells were transfected with µ1, σ3 or µNS encoding plasmids A) 
individually or B) in combination as indicated. Cells were fixed 24 h post-transfection 







Figure 3.2: Dependence of µ1 on σ3 for recruitment to VFLs and VFs. The images in 
A were prepared by Caroline Coffey and reassembled into this figure (9). The images 
in B were reacquired by S. Kaufer. A) CV-1 cells were triply transfected with 
plasmids encoding µ1, σ3 and µNS. B) CV-1 cells were infected with reovirus tsG453 
(MOI=5) and either incubated at 32°C for a total of 24 h or for 2 h at 32°C and then 
shifted to 39°C for an additional 18 h. Cells were fixed 24 h post-transfection or 




Figure 3.3: Heat shock or over-expression of Hsc70 increases the frequency of σ3 
localization to VFLs. The data were collected by Caroline Coffey and reassembled 
into this figure (9). CV-1 cells were transfected with plasmids encoding σ3, µNS and 
Hsc70 (right graph). Heat shock was carried out by incubating cells at 42°C for 15 min 
at 18 h post-transfection and a following 6 h recovery period at 37°C. Cells were fixed 
24 h post-transfection and immunostained for σ3 and µNS. Cells were analyzed for σ3 
localization to µNS VFLs by immunofluorescence. The mean and SD of three 
experiments is shown. 
 
Co-localization of Hsc70 and µ1 in transfected and infected cells. A 
corollary of the inability of µ1 to be recruited to VFs in the absence of σ3 is that 
assembly of the μ1:σ3 heterohexamer likely occurs outside of VFs. The assembly of 
large oligomeric complexes within the cytosol often requires cellular chaperones. 
Given the potential role of Hsc70 in σ3 recruitment to VFLs, I sought to investigate 
whether Hsc70 also had an influence on µ1. I transfected cells with a µ1 encoding 
plasmid and analyzed the subcellular distribution of endogenous Hsc70 in correlation 
to µ1. In mock transfected cells Hsc70 was diffusely distributed in the cytosol and the 
nucleus. As previously described, µ1 localized predominantly to lipid droplets which 
were visualized by staining for neutral lipids with Oil Red O (10). In cells expressing 
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µ1 I saw a concentration of Hsc70 around these lipid droplets which co-localized with 
µ1 staining (Figure 3.4). A similar localization pattern was observed in reovirus 
infected cells. Hsc70 was still diffusely distributed in the cytosol and the nucleus, but 
in addition showed pronounced recruitment to µ1-bound lipid droplets (Figure 3.4). 
This recruitment was consistent in different reovirus strains T1L, T3DCD and T3DN 
(data not shown for T1L and T3DCD). Besides the co-localization with µ1, I also noted 




Figure 3.4: Co-localization of Hsc70 and µ1 on lipid droplets in transfected and 
infected cells. CV-1 cells were transfected with a mock vector or a µ1-encoding 
plasmid (M2(L)). CV-1 cells were also infected with reovirus T3DN (MOI=5). Cells 
were fixed 24 h post-transfection or infection and immunostained for µ1 and Hsc70. 
Lipid droplets were visualized by staining with Oil Red O. Scale bars, 10 µm. 
 
Hsc70 interacts with µ1. As Hsc70 co-localized with µ1 on lipid droplets in 
infected and transfected cells, I used immunoprecipitation to further investigate the 
interaction between these two proteins. I transfected 293F cells with a μ1-encoding 
plasmid and then prepared lysates for co-immunoprecipitation assays using an anti-
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Hsc70 antibody. Coffey et al previously showed that the normally low expression 
level of µ1 in transfected cells can be augmented by treating the cells with a broad-
spectrum caspase inhibitor (10). Thus I treated the 293F cells with Q-VD-Oph in order 
to achieve higher µ1 protein levels. I was able to co-immunoprecipitate µ1 along with 
Hsc70 using an anti-Hsc70 antibody (Figure 3.5A). The control antibody (Tsp) did not 
immunoprecipitate Hsc70 or µ1. Similarly, in the reverse experiment Hsc70 co-
immunoprecipitated with μ1 using an anti-µ1 antibody (10F6) (Figure 3.5B). Again, 
the control antibody anti-H5 hemagglutinin did not pull down Hsc70 or µ1. I conclude 





















Figure 3.5: Immunoprecipitation of µ1 and the µ1:σ3 heterohexamer by Hsc70. A) and 
B) 293F cells were transfected with a µ1-encoding plasmid and treated with 10 µM Q-
VD-Oph. 24 hpt cell lysates were prepared and A) µ1 was co-immunoprecipitated 
using anti-Hsc70 antibody or B) Hsc70 was co-immunoprecipitated using anti-µ1 
10F6 antibody. Asteriks in A) denotes µ1 band. Isotype matched control antibodies 
were anti-Trichinella spiralis (Tsp) for anti-Hsc70 and anti-H5 hemagglutinin for anti-
µ1 10F6. C) 293F cells were co-transfected with σ3, µ1 and Hsc70-EGFP encoding 
plasmids for 24 h. D) 293F cells were infected with reovirus T1L (MOI=5) for 24 h. 
C) and D) Cell lysates were prepared and proteins were immunoprecipitated using 
antibodies against Hsc70, µ1 (10F6) or σ3 (5C3). Isotype matched control antibodies 
were anti-Trichinella spiralis (Tsp) for anti-Hsc70 and anti-H5 hemagglutinin for anti-
µ1 10F6 and anti-σ3 5C3. Immunoblots (IB) were probed with anti-Hsc70 antibody 
and antisera against T1L (anti-µ1) and σ3. Volume of lysate loaded corresponds to 5% 




Hsc70 interacts with the µ1:σ3 heterohexamer. In order to test the 
hypothesis that Hsc70 could aid the formation of the µ1:σ3 heterohexamer, I wanted 
to investigate whether Hsc70 was associated with this complex. I co-transfected 293F 
cells with µ1- and σ3-encoding plasmids or infected 293F cells with reovirus strain 
T1L. In both cases, antibodies against Hsc70 co-immunoprecipitated µ1 and σ3 
(Figure 3.5C and D). Given that Hsc70 interacts with µ1 alone, this result could 
indicate that Hsc70 interacts with both proteins only on an individual base. However, 
despite performing multiple experiments under different immunoprecipitation 
conditions, I was unable to show any association of Hsc70 with σ3 when they were 
co-expressed together (data not shown). Thus, I conclude that co-immunoprecipitation 
of µ1 and σ3 with Hsc70 indicates that Hsc70 associates with the assembled 
heterohexamer and not the individual proteins. 
Although antibodies against µ1 (10F6) and σ3 (5C3) were able to co-
immunoprecipitate the respective other protein, neither antibody was capable of co-
immunoprecipitating Hsc70. This might be due to steric hindrance of Hsc70 versus 
antibody binding. Another possible explanation is that association of Hsc70 with the 
heterohexamer occurs transiently during assembly and thus by targeting the chaperone 
in immunoprecipitation, I could enrich the pull down for this specific intermediate. In 
order to stabilize the potentially transient interaction between Hsc70 and the µ1:σ3 
heterohexamer, I co-transfected a dominant negative mutant of Hsc70, Hsc70-T204V-
EGFP. This mutant is predominantly ADP-bound and thus releases its substrate at a 
slower rate (26). I hypothesized that co-expression of Hsc70-T204V-EGFP, which 
displays more stable substrate association, might enhance the co-immunoprecipitation 
of Hsc70 and the heterohexamer. I found that co-expression of this mutant facilitated 
the co-immunprecipitation of µ1 and σ3. However, further experiments revealed that 
this effect was not due to the enhanced substrate affinity of Hsc70. Over-expression of 
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wild type Hsc70-EGFP had a similar beneficial effect on the pull down of µ1 and σ3 
by anti-Hsc70 antibody. This finding was unexpected and I can only provide a 
speculative explanation. I hypothesize that the enhancement of µ1 and σ3 pull down 
was due to the inherent dimerization properties of EGFP. Heterohexamer-bound 
Hsc70-EGFP might dimerize via the EGFP-tag and thus an anti-Hsc70 antibody could 
pull down multiple aggregates of µ1-σ3-Hsc70-EGFP. This hypothesis could be tested 
by using a differently tagged version of Hsc70. However, the co-immunoprecipitation 
of µ1 and σ3 with Hsc70 from infected cells was not influenced by exogenous Hsc70 
or the presence of foreign protein tags and was achieved in two different virus strains, 
T1L and T3DCD (data not shown for T3DCD). Thus, we conclude from our findings 
that Hsc70 interacts not only with µ1 alone, but also with the µ1:σ3 heterohexamer. 
Dominant negative mutants of Hsc70 do not co-localize with µ1. Most 
proteins that interact with Hsc70 are chaperone substrates with exposed hydrophobic 
regions and depend on the chaperoning activity of Hsc70. Dominant negative forms of 
Hsc70 do not bind substrates (17). To investigate if µ1 behaves like a substrate of 
Hsc70, I expressed dominant negative mutants of Hsc70 with µ1 and examined their 
potential to co-localize with µ1. The dominant negative mutants of Hsc70 all have a 
mutation in their nucleotide binding site that affects the chaperone ATP-ADP-cycle 
(24). The ATPase rate of Hsc70-K71M is undetectable, while it is reduced 50-fold in 
Hsc70-D199S (25, 37). This means that these two mutants are predominantly ATP 
bound and that their substrate on-off rate is fast. Hsc70-T204V has a normal ATP 
hydrolysis activity together with a 100-fold reduced ATP binding activity (26). Thus, 
Hsc70-T204V is mainly ADP bound and binds and releases its substrate slowly. As 
the anti-Hsc70 antibody can not distinguish between endogenous wild type Hsc70 and 
mutant Hsc70, we HA-tagged the dominant negative mutants C-terminally. 
Upon co-expression of µ1 and each of the dominant negative mutants of 
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Hsc70, I found that none of the mutants co-localized with µ1. All three mutants were 
diffusely distributed in the cytosol and nucleus. µ1 localized to lipid droplets (Figure 
3.6). The loss of co-localization of the dominant negative mutants of Hsc70 with µ1 
was not due to the HA-tagging of the mutants, as HA-tagged wild type Hsc70 was still 
recruited to lipid droplets in the presence of µ1. As another control we HA-tagged the 
VP1 capsid protein of feline calicivirus strain FCV5. There was no association 
between the VP1 protein and lipid droplets or Hsc70 (Figure 3.6 control). The result 
that dominant negative forms of Hsc70 no longer co-localized with µ1 indicates that 




Figure 3.6: Hsc70 co-localization with µ1 depends on Hsc70s chaperone function. 
CV-1 cells were co-transfected with plasmids encoding µ1 and either wild type Hsc70 
(WT) or a dominant negative mutant of Hsc70 (K71M, D199S, T204V). All Hsc70 
proteins were HA-tagged. As a control the HA-tagged VP1 protein of calicivirus 
FCV5 was co-transfected (control). Cells were fixed 24 hpt and immunostained using 




Effect of Hsc70 knockdown on µ1 localization. To test the idea that Hsc70 
might be important for µ1 localization to lipid droplets, I depleted Hsc70 from CV-1 
cells using small interfering RNA (siRNA) and then transfected the cells with a 
plasmid encoding μ1. I measured the efficiency of depletion of Hsc70 by immunoblot 
and detection by infrared scanning and found that after treatment with Hsc70 siRNA 
68%, 87%, and 96% of Hsc70 was depleted at 48 h, 72 h, and 96 h post-treatment, 
respectively (Figure 2.2). To evaluate the role of Hsc70 in µ1 localization to lipid 
droplets I treated cells with Hsc70 or control siRNA and transfected with a μ1-
encoding plasmid 24 h post siRNA treatment. I could not detect any effect of the 
absence of Hsc70 on the recruitment of µ1 to lipid droplets. µ1 still localized 




Figure 3.7: Knockdown of Hsc70 has no effect on µ1 recruitment to lipid droplets. 
CV-1 cells were transfected with control or Hsc70 siRNA. 24 h after siRNA treatment, 
cells were transfected with a µ1-encoding plasmid. Cells were fixed 48, 72 and 96 h 
post siRNA treatment and immunostained for Hsc70 and µ1. Scale bar, 10 µm. 
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Discussion 
The process of reovirus assembly is not fully understood. Replication and 
assembly of new virions is thought to occur in viral factories (VFs) (29). The 
recruitment of the major outer capsid proteins µ1 and σ3 to viral factories has not been 
investigated extensively so far. σ3 has been observed to be recruited to VFs in infected 
cells, but it has not been determined if this association is dependent on other viral 
proteins. Coffey et al showed that µ1 is diffusely distributed in the cytosol at early 
time points and only localizes to VFs at later time points in infection (10). Coinciding 
with factory recruitment µ1 also targets membranous structures like the endoplasmic 
reticulum, mitochondria and lipid droplets (10). We found that σ3 was able to co-
localize with µNS VFLs, but that µ1 was not recruited to VFLs if co-expressed with 
µNS. We detected µ1 at VFLs only in the presence of σ3, indicating a dependence of 
µ1 on σ3 for recruitment to VFLs. This finding was supported in infection 
experiments using a temperature sensitive mutant of σ3, tsG453. At the restrictive 
temperature this strain does not produce viable σ3 protein and we did not observe any 
association of µ1 with viral factories. These findings suggest that µ1 and σ3 are 
recruited to VFs together, most likely in the form of the heterohexamer which is the 
building block of the outer capsid. Although the possibility exists that σ3 and µ1 
might be co-recruited in a different form and arrange into the heterohexamer within 
viral factories, it seems unlikely. The heterohexamer has been purified from insect 
cells co-expressing µ1 and σ3 showing that this complex can assemble independently 
of viral factories (18). The question remains why µ1 is not independently recruited to 
VFs. Maybe µ1 binding to Hsc70 prevents association with VFs until µ1 has 
assembled with σ3 into the heterohexamer. Uncomplexed µ1 could coat cores in a 
manner that would impair proper outer capsid formation and generate defective 
virions. 
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µ1 has been found to induce apoptosis in transfected as well as infected cells 
(10, 11). This occurs late in infection and is thought to be a viral strategy of egress and 
spread rather than a host defense mechanism (10, 30). It is unclear how the virus 
prevents apoptosis induction from happening too early as this would negatively impact 
progeny virion generation. The apoptotic capacity of µ1 is abrogated in the presence 
of σ3 most likely due to the assembly of the two proteins (10). Thus assembly could 
represent a means of regulating apoptosis induction by µ1. In the heterohexamer µ1 
assumes a trimeric conformation, but it has not been investigated what conformational 
status µ1 has when it is not complexed with σ3. It seems likely that µ1, as monomer or 
trimer, has exposed hydrophobic regions which could lead to aggregation or 
misfolding. I have found that µ1 interacts with the cellular chaperone Hsc70 and that 
the two proteins co-localize on lipid droplets. This co-localization was dependent on 
the chaperoning function of Hsc70, but in the absence of Hsc70, µ1 was still targeted 
to lipid droplets. It is likely, though, that other chaperones mask a potential phenotype 
caused by Hsc70 depletion as I also detected Hsp70, the inducible form of Hsc70, on 
lipid droplets when µ1 was expressed (unpublished data). My findings suggest that µ1 
is a substrate for Hsc70. I was also able to show an interaction of Hsc70 with the 
µ1:σ3 heterohexamer which is likely mediated by binding of Hsc70 to µ1 as I could 
not detect an association of σ3 and Hsc70. I speculate that heterohexamer formation 
might take place on lipid droplet membranes with the aid of Hsc70. Further 
experiments are necessary to substantiate this hypothesis. It has been reported that 
capsid proteins of Hepatitis C virus and dengue virus localize to lipid droplets and that 
these structures play a role in virus production (22, 31). Although µ1 localizes 
predominantly to lipid droplets, it also localizes to membranes of the endoplasmic 
reticulum (ER) and mitochondria and has been implicated in the penetration of these 
membranes (10). The ER and mitochondria membrane are both lipid bilayers, while 
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lipid droplets are composed of a single leaflet. The single leaflet membrane of lipid 
droplets might be immune to the membrane destabilizing effect of µ1 and thus pose a 
better place for the heterohexamer assembly than a bilayer membrane susceptible to 
penetration. 
The fact that I was unable to find an association of σ3 and Hsc70 left me 
puzzled in light of data that showed an increase of the frequency of σ3 recruitment to 
VFLs after over-expression of Hsc70. I had hypothesized that Hsc70 would interact 
with σ3 and probably influence the conformation of σ3 allowing for a more efficient 
recruitment to VFLs. My findings do not support this hypothesis. Preliminary 
experiments suggest that σ3 localization to VFLs might not be a specific recruitment, 
but rather a non-specific entrapment. In related work I investigated the recruitment of 
Hsc70 to viral factories and found in immunoprecipitation assays that the substrate-
binding domain was solely responsible for the interaction (15). However, in 
immunofluorescence experiments the ATPase domain localized to VFLs as well 
although it did not interact by immunoprecipitation. I discovered that this co-
localization was an artifact caused by paraformaldehyde (PFA) fixation of cells and 
was overcome by using methanol. Similarly, I found that non-specific recruitment of 
GFP to VFLs was resolved by fixing cells with methanol. These findings lead me to 
speculate that small sized proteins might be able to diffuse into the µNS matrix and 
get trapped there by PFA fixation. σ3, like the ATPase domain of Hsc70 and GFP is 
only around 40 kDa and thus I hypothesized that σ3 localization to VFLs could 
likewise be a fixation artifact. Preliminary experiments using methanol fixation did 
indeed abolish the association of σ3 and µNS even after over-expression of Hsc70. 
Further experiments are necessary to conclusively determine if σ3 localization to µNS 
is real or artifactual. 
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However, previous findings in our lab indicated a role for Hsc70 in the 
recruitment of σ3 to VFLs. Given the fact that there seems to be no direct interaction 
between the two proteins, the question remains how Hsc70 promotes this recruitment? 
I recently investigated the localization of Hsc70 to viral factories. I found that 
although µNS is bound via the substrate-binding domain, it does not appear to be a 
substrate in the sense of a misfolded protein (15). The formation of viral factories was 
not impacted in the absence of Hsc70, and µNS also interacted with a dominant 
negative mutant of Hsc70 (15). I hypothesize that Hsc70 is involved in virus 
assembly. Additionally, Hsc70 might affect the µNS matrix of viral factories. It is 
thought that µNS forms small oligomers prior to assembling into larger multimeric 
complexes to create viral factories, but as an atomic resolution structure of µNS is 
unavailable, the nature of such an oligomer is unknown. Live cell microscopy has 
revealed that viral factories are dynamic and can fuse with other VFs in an infected 
cell (Parker, unpublished observation). These dynamic properties and the necessity for 
incorporation of larger viral proteins (140 kDa) into the viral factories require a certain 
flexibility of the µNS matrix. Hsc70 might regulate the accessibility of viral factories 
by rearranging µNS oligomers. Over-expression of Hsc70 would thus increase the 
permeability of the VFL matrix and more σ3 could gain access (Figure 3.8). 
Depending on the fixation method, σ3 would become fixed in place by PFA, while 





Figure 3.8: Model of Hsc70 influence on VF accessibility. Under normal Hsc70 
expression conditions µNS is predominantly in a closed conformation allowing only 
moderate access of proteins. With Hsc70 over-expression more µNS changes to a 
open conformation which leads to an influx of proteins. 
 
In summary, I have shown that µ1 and σ3 are most likely recruited to viral 
factories as a pre-assembled complex. Furthermore, I have demonstrated an interaction 
between µ1 and Hsc70 and between the µ1:σ3 heterohexamer and Hsc70. Future 
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Possible regulation of reovirus induced apoptosis by caspase cleavage and 
ubiquitination of outer capsid protein µ1 
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Abstract 
Mammalian orthoreoviruses cause encephalitis and myocarditis in newborn 
mice secondary to virus-induced apoptosis. The primary determinant of reovirus-
induced apoptosis is the outer capsid protein μ1. µ1 co-assembles with σ3 to form a 
heterohexameric complex and large amounts of µ1 are detected in infected cells. 
However, when expressed ectopically, the levels of detectable µ1 are low, suggesting 
that µ1 is unstable and degraded when expressed alone. Here we show that µ1 is 
ubiquitinated and upon induction of apoptosis is cleaved by cellular caspases. 
Mutation of a canonical caspase cleavage motif at position 487-490 increased the 
levels of ectopically expressed µ1. Although mutant forms of µ1 were expressed at 
higher levels, they induced similar levels of caspase 3/7 activation as the wild type 
protein; however, cell viability was increased. Ubiquitination of wild type µ1 was 
greatly increased after pan-caspase inhibition. In contrast, inhibition of caspase 
cleavage through mutation of the caspase cleavage site did not result in enhanced 
ubiquitination. A recombinant mutant virus bearing a mutation at the caspase cleavage 
site in µ1 had overall similar single cycle growth kinetics, but displayed a potential 
entry defect. In addition, this recombinant mutant virus had lower growth kinetics 
when infected at low moi. These findings suggest a possible regulation of cell death by 
caspase cleavage of µ1 and indicated a link between caspase cleavage and 
ubiquitination of µ1. 
 100 
Introduction 
Mammalian orthoreovirus (reovirus) consist of a double layered, non-
enveloped capsid and contain a genome of ten double-stranded RNA (dsRNA) 
segments. Reovirus infections are asymptomatic in healthy adults, but cause pathology 
in newborn mice in the CNS, myocardium, hepatobiliary system, lungs and endocrine 
tissue (33). Myocarditis and encephalitis are the two most studied reovirus-induced 
diseases. The cytopathic effects seen in the CNS and heart co-localize with regions of 
reovirus replication and apoptosis induction (24, 28). Studies have shown that 
inhibition of apoptosis reduces tissue damage, curtails disease progression in the CNS 
and is protective in the heart (9, 10, 25, 26). 
The outer capsid protein µ1 is responsible for reovirus-induced apoptosis in 
infection and also causes apoptosis in transfected cells (5, 7). µ1 is a 76 kDa protein 
and is a major component of the outer capsid layer where it occurs in a complex with 
the viral structural protein σ3 (21). During virus entry σ3 is proteolytically removed 
and µ1 itself undergoes proteolytic cleavage which gives rise to the intermediate 
subviral particle (ISVP) (11). Cleavage of µ1 results in the generation of three µ1 
fragments. The N-terminal µ1N (4 kDa) and C-terminal Φ (13 kDa) fragments are 
released from the ISVP and have both been implicated in membrane penetration (6, 
17, 19, 34). The central δ part is removed from the entering ISVP in the cytosol in a 
chaperone-aided process that generates the core particle (16). The region of µ1 
necessary and sufficient for apoptosis induction in vitro has been identified as the Φ 
fragment (5). In infection the amount of µ1 protein is high compared to ectopic 
expression where µ1 levels are low. Coffey et al. showed that the detectability of µ1 is 
improved in the presence of pan-caspase inhibitors, suggesting that µ1 is a target for 
caspase-mediated cleavage (5). 
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Caspases constitute a family of cystein-dependent aspartate-directed proteases 
that are activated during apoptosis (12). They are expressed as inactive zymogens with 
an N-terminal prodomain followed by a large and a small subdomain. Caspase 
activation requires two cleavage events which remove the prodomain and separate the 
large and small subunit. The latter two remain associated and form a homo- or 
heterodimer together with two subdomains of another cleaved zymogen to generate an 
overall tetrameric, active caspase. Two subclasses of caspases can be distinguished in 
apoptosis, iniator and effector caspases. Initiator and effector caspases form a cascade 
where activated initiator caspases cleave and activate effector caspases, such as 
caspase 3, 6 and 7 which in turn cleave cellular proteins and thus induce apoptosis. 
The activation of initiator caspases such as caspase 2, 8, 9 and 10 occurs in association 
with a multimeric scaffold (12). These scaffolds form upon an external or internal 
stimulus and recruit inactive initiator caspases which due to the increased local 
concentration and/or a conformational change are able to cleave and activate each 
other. Such stimuli can be the binding of certain plasma membrane receptors (Fas, 
TNFR1, DR4, DR5) by their respective ligand (FasL, TNFα, TRAIL) or the release of 
proapoptotic proteins such as cytochrome c and smac/DIABLO from the 
intermembrane space of mitochondria into the cytosol. 
It seems unlikely, however, that cleavage of µ1 by caspases is solely 
responsible for the low levels of µ1 in transfected cells. Coffey et al. found that the C-
terminal Φ region of µ1 contains a PEST motif (5). PEST motifs are regions of twelve 
or more amino acids rich in proline (P), glutamate (E), serine (S) and threonine (T) 
flanked by lysine (K), arginine (R) or histidine (H) residues (27). Such sequences are 
often signals for phosphorylation and subsequent ubiquitination and degradation by 
the 26S proteasome. For example, the nuclear transcription factor NF-κB is retained in 
the cytosol by the binding of inhibitors of κB (IκB) which mask NF-κB’s nuclear 
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localization signal. Given a certain stimulus IκB becomes phosphorylated within its 
PEST motif which in turn triggers ubiquitination of IκB and degradation by the 26S 
proteasome (18, 22, 23). It is unknown if µ1 is also phosphorylated, but preliminary 
data suggested that µ1 might be ubiquitinated (4). Ubiquitination is the process of 
covalent linkage of the 76 amino acid protein ubiquitin to a lysine residue in a target 
protein. This process involves at least three different proteins, an ubiquitin-activating 
enzyme (E1), an ubiquitin-conjugating or carrier enzyme (E2) and an ubiquitin ligase 
(E3) (14). E1 enzymes bind and thereby activate ubiquitin in an ATP-dependent 
manner. They then hand off the activated ubiquitin to the E2 enzyme which in 
conjunction with the E3 ligase transfers the ubiquitin onto the target protein. 
Modification of proteins with ubiquitin often occurs in the form of polyubiquitination, 
meaning that a chain of covalently bound ubiquitin monomers is linked to a target 
protein. A minimum of four ubiquitin moieties has been found to be necessary for 
interaction of an ubiquitin chain with the proteasome (29). The proteasome is a large 
multi-subunit complex which degrades proteins by hydrolyzing peptide bonds and 
thus cleaves proteins into small oligopeptides that in turn are further broken down into 
free amino acids that get recycled (13). 
Here I investigated the relation between caspase inhibition and the increased 
steady state levels of µ1 and also the possible ubiquitination of µ1. These findings 
might be relevant for the understanding of the regulation of apoptosis induction by µ1. 
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Materials and Methods 
Cells and viruses. CHO-S cells and 293F cells were maintained at 37ºC, 8% 
CO2 in spinner culture (125 rpm) in CHO-S Serum Free Media II (Gibco) and 
FreeStyle™ 293 Expression Medium (Gibco), respectively, supplemented with 50 U 
ml-1 penicillin, 50 µg ml-1 streptomycin and 125 ng ml-1 amphotericin B (antibiotic-
antimycotic solution, Cellgro). CV-1 cells were grown at 37°C in 5% CO2 in Eagles 
Minimum Essential Medium (MEM) (CellGro) supplemented with 10% fetal bovine 
serum (HyClone), 100 U ml-1 of penicillin, 100 µg ml-1 streptomycin, 250 ng ml-1 
amphotericin B (antibiotic-antimycotic solution, Cellgro), 50 µg ml-1 gentamycin, and 
non-essential amino acids (CellGro). HeLa cells (ATCC; CCL2) were maintained at 
37ºC, 5% CO2 in Dulbecco’s Modified Eagle’s Medium containing 10% fetal bovine 
serum (HyClone), 100 U ml-1 of penicillin, 100 µg ml-1 streptomycin, 250 ng ml-1 
amphotericin B (antibiotic-antimycotic solution, Cellgro), 50 µg ml-1 gentamycin, and 
non-essential amino acids (CellGro). BHK-T7 cells were a kind gift from Dr. Ursula 
Buchholz and were maintained at 37ºC, 5% CO2 in Glasgow MEM (Invitrogen) 
containing 5% fetal bovine serum (HyClone), 2 mM glutamine (Cellgro), 100 U ml-1 
of penicillin, 100 µg ml-1 streptomycin, 250 ng ml-1 amphotericin B (antibiotic-
antimycotic solution, Cellgro), 50 µg ml-1 gentamycin, non-essential amino acids 
(CellGro) and 1 mg ml-1 Geneticin (Mediatech). Reoviruses T1L and T3D were 
laboratory stocks of the isolates previously identified as T1/human/Ohio/Lang/1953 
and T3/human/Ohio/Dearing/1955, respectively. The superscript N in T3DN 
differentiates a laboratory stock obtained from the Nibert laboratory from a T3D clone 
obtained from L. W. Cashdollar (Medical College of Wisconsin), denoted T3DCD. The 
T3DCD clone differs from the T3DN clone in viral factory morphology and in the 
nucleotide sequence of its M1 genome segment. Viruses were plaque-isolated and 
amplified in murine L929 cells in Joklik's modified minimal essential medium (Gibco) 
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supplemented with 4% fetal bovine serum (HyClone), 2 mM glutamine (Cellgro), 100 
U ml-1 penicillin, 100 µg ml-1 streptomycin, 250 ng ml-1 amphotericin B (antibiotic-
antimycotic solution, Cellgro) and 50 µg ml-1 gentamycin (Cellgro). 
Plasmids. pCI-M2(N), pCI-M2(N)-1-582 (µ1δ) were previously described (4). 
To create N- and C-terminal fusions of µ1, we subcloned the M2(N) gene into 
pEGFP-N and pEGFP-C (Clontech). The plasmids pMT107 (His-polyubiquitin) and 
pMT123 (His-c-jun) were kind gifts from Dr. Dirk Bohmann (30) and the reovirus 
genes encoding pT7 plasmids for the reverse genetics system were a kind gift from Dr. 
Terence Dermody (20). The caspase cleavage mutants D16N, D80N, D97E, D145E, 
D176N, D191A, D474N, D487N, D490E, D490N, D517N and D684K. The alanine 
scanning mutants Q485A, P486A, D487A, V488A, W489A, D490A, L492A, L493A, 
M494A and T495A were generated by standard mutagenesis technique. Primers and 
cloning strategies available upon request. 
Antibodies and reagents. Rabbit polyclonal antisera against T3D reovirus 
was a gift from B. Sherry. Mouse monoclonal antibodies (mAbs) 4A3, 10H2, and 
10F6 specific for μ1 and rabbit polyclonal antisera against T1L virion and σ3 have 
been described previously (31, 32). Mouse mAb anti-GFP was obtained from 
Clontech, mouse polyclonal antibody anti-6xHis was purchased from Novagen and 
mouse mAb anti-poly-ubiquitin (FK1) and FITC-conjugated goat anti-mouse IgM 
were obtained from Biomol. Secondary antibodies for immunofluorescence (IF) 
microscopy were goat anti-mouse immunoglobulin G (IgG and IgG2b), goat anti-rabbit 
IgG conjugated to Alexa 488 or Alexa 594 (Invitrogen). Secondary antibodies for 
immunoblot detection were donkey anti-rabbit IgG, donkey anti-mouse IgG and goat 
anti-chicken IgY conjugated to horseradish peroxidase (HRP) (Jackson 
ImmunoResearch). Secondary antibodies used with the Odyssey Infrared Scanner (LI-
COR) were IRDye 800CW goat anti-mouse IgG and IRDye 680 goat anti-rat IgG (LI-
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COR). Antibodies were titrated to optimize signal-to-noise ratios. To determine cell 
viability we used the Live/Dead Cell Viability Kit (Molecular Probes, Invitrogen). 
Pan-caspase inhibitor q-VD-Oph was purchased from Kamiya Biomedical Company. 
Caspase 3/7 activation. Caspase 3/7 activity was determined with a FLICA 
caspase 3/7 kit (Immunochemistry Technologies, LLC). Briefly, cells were pelleted at 
500 × g, 5 min, 4ºC and washed in 1 ml PBS. Cells were resuspended in 300 µl PBS 
containing 5 µl FLICA reagent and incubated for 1 h in the dark. Cells were washed 
twice in PBS and fixed in 3.7% formaldehyde in PBS for 15 min in the dark. Cells 
were washed three more times in PBS and analyzed by flow cytometry. 
Transfections and infections. CHO-S cells were transfected with FreeStyle 
MAX reagent (Invitrogen, Grand Island, NY) according to the manufacturer’s 
instructions. The plasmid-FreeStyle MAX mixture was inoculated in 2 ml single cell 
suspension (1.0-1.2 × 106 cells per ml) of CHO-S cells and incubated for 24 h in 
antibiotic-free medium. Caspase inhibitor (q-VD-Oph, final concentration 10 μM) was 
supplemented during transfection. CV-1 cells were seeded the day before transfection 
or infection at a density of 5 × 104  cells per well in twelve-well plates containing 18-
mm-diameter round glass cover slips. CV-1 cells were transfected using FuGene HD 
transfection reagent (Roche) according to the manufacturer’s instructions. A 7:2 ratio 
of FuGene HD reagent to DNA was used. 293F cells were transfected using 293fectin 
(Invitrogen) according to the manufacturer’s instructions. The day before transfection 
293F cells were set up at a density of 5-7 × 105 cells per ml in 28 ml of antibiotic-free 
FreeStyle™ 293 Expression Medium. A 2:1 ratio of 293fectin to DNA was used. 
HeLa cells were seeded the day before transfection or infection at a density of 1 × 105 
cells per well in twelve-well plates containing 18-mm-diameter round glass cover 
slips. HeLa were transfected with FuGene 6 transfection reagent (Roche) according to 
the manufacturer’s instructions. A ratio of 3:2 of FuGene 6 to DNA was used. BHK-
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T7 cells were transfected using TransIT-LT1 (Mirus) as described in (20). 
Immunofluorescence (IF) microscopy. Cells on cover slips were fixed for 10 
min at room temperature in 2% paraformaldehyde in PBS, washed 3 times in PBS, 
then permeabilized for 15 min in PBS containing 1% bovine serum albumin (BSA), 
0.1% Triton X-100 and 0.05% sodium-azide (PBSA-T). All antibody incubations were 
carried out for 30 min at room temperature in PBSA-T. Cover slips were washed 3 
times in PBS between primary and secondary antibody incubations. Cover slips were 
mounted on glass slides with ProLong + DAPI reagent (Molecular Probes). 
Fluorescence and phase images were obtained with a Nikon TE2000 inverted 
microscope equipped with fluorescence and phase optics through a 60 × 1.4 NA oil 
objective with 1.5 × optical zoom. Images were collected digitally with a Coolsnap 
HQ CCD camera (Roper) and Openlab software (Improvision) then were prepared for 
publication using Photoshop and Illustrator software (Adobe Systems). Graphs were 
prepared using Kaleidagraph (Synergy Software). 
Ni-NTA pulldown of His-polyubiquitin-tagged conjugates. Method was 
adapted from (1). 293F cells were transfected with wild type or mutant pCI-M2(L) and 
either pMT107 (His-polyubiquitin) or pMT123 (His-c-jun). 24 h post-transfection 
cells were harvested by centrifugation (5 min at 500 × g, 4°C) and washed twice in 
cold PBS. The cell pellet was resuspended in 1 ml of PBS and 60 µl of the PBS-cell 
suspension were retained and lysed by sonication (2 × 30 sec, duty cycle 20-30%, 
power 2-3). This small aliquot of lysate was used for quantification of total protein 
levels (Biorad DC protein assay) and as source for the total cell lysate in 
immunoblotting. The remaining cell suspension was pelleted and lysed in 1 ml of 
Buffer A (6 M guanidine-HCl, 0.1 M Na2HPO4/NaH2PO4, 10 mM imidazole, pH 8). 
The cell lysate was sonicated 2 × 30 sec at duty cycle 50% and power 5. 150 µl of 
unsettled 50% Ni-NTA agarose slurry (QIAGEN) was washed 3 times in 1 ml of 
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Buffer A. Equal amounts of protein were incubated with the Ni-NTA agarose for 3 h 
at room temperature while turning. After incubation the protein-bound agarose was 
washed twice in 1 ml of Buffer A, then twice in 1 ml of Buffer A/TI (1:3 v/v) and 
once in 1 ml of Buffer TI (25 mM Tris-HCl, 20 mM imidazole, pH 6.8). Residual 
buffer was sucked out with a 27 gauge needle. Purified proteins were eluted by boiling 
the agarose for 7 min at 95°C in 50 µl of 5× SDS sample buffer and 10 µl of 10 M 
imidazole and analyzed by SDS-PAGE and immunoblotting. 
Immunoblotting. Proteins separated by SDS polyacrylamide gel 
electrophoresis (PAGE), were transferred to nitrocellulose membranes and blocked for 
30 min at room temperature in 1 × PBS (pH 7.4) containing 0.1% Tween-20, 100 U 
ml-1 penicillin, 100 µg ml-1 streptomycin and 5% powdered milk. Proteins were 
detected with primary antibodies in blocking buffer for 1 h at RT or overnight at 4°C. 
Membranes were washed 3 × 5 min in 1 × TBST before incubation with secondary 
antibodies for 1 h at RT and final washes of 6 × 5 min in 1 × TBST. Secondary 
antibodies were detected with SuperSignal West Pico Chemiluminescent Substrate 
(Pierce) and fluorography. For consecutive probing with different antibodies, 
immunoblots were stripped with 10% SDS, 6.25 mM Tris, 143 mM β-
mercaptoethanol, heated to 65°C for 15 min at room temperature, followed by 3 × 5 
min washes in 1 × TBST. 
Flow cytometry analysis. Transfected cells were harvested by centrifugation 
(500 × g, 5 min, 4°C) and fixed for 15 min at room temperature with 1% 
paraformaldehyde in PBS. Cells were washed twice in 1 ml PBS and resuspended in 1 
ml permeabilization buffer (0.15% Triton X-100, 2% bovine serum albumin, 5% fetal 
bovine serum in PBS) for 30 min at room temperature. Primary antibodies were 
incubated in 1 ml of 1% bovine serum albumin and 0.1% Triton X-100 in PBS for 1 h. 
Secondary antibodies were incubated in 1 ml of 0.1% Triton X-100 in PBS for 30 min 
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in the dark. Between antibody incubations, cells were washed twice in 1 ml of PBS. 
After the secondary antibody incubation cells were washed twice in 1 ml of PBS and 
resuspended in a final volume of 500 µl. Samples were measured using a 
FACSCalibur (BD Biosciences) and analyzed with CellQuest software (BD 
Biosciences) and FlowJo software (Tree Star, Ashland, OR). 
Statistical analysis. Prism (GraphPad Software) statistical analysis software 
was used for statistical analyses. Data shown represent a minimum of three 




Treatment of cells with pan-caspase inhibitors increases the steady-state 
levels of µ1 in transfected CHO-S cells. Ectopic expression of reovirus outer capsid 
protein μ1 induces apoptosis in ~30% of transfected CHO cells, and the Φ region of 
μ1 is both necessary and sufficient for this activity (5) (see Figure 4.1A for diagram of 
μ1 fragments). The steady-state levels of μ1 in transfected cells are low as detected by 
immunoblotting with rabbit anti-reovirus virion serum compared to levels in infected 
cells (5). However, when transfected cells were treated with the pan-caspase inhibitor 
q-VD-Oph at the time of transfection, the levels of full-length μ1 increased 
approximately 4-fold (Figure 4.1B). In addition to a prominent band of ~ 76 kDa 
representing full-length µ1, I detected several additional immunoreactive bands of 
lower molecular weight in lysates from transfected cells treated with q-VD-Oph 
(Figure 4.1B). These bands were absent or of much lower intensity in lysates from 
vehicle-only treated µ1-transfected cells. In contrast, ectopic expression levels of the 
µ1δ fragment, which does not induce apoptosis in transfected cells, were unaffected 
by q-VD-Oph (Figure 4.1B). Based on these findings, I hypothesized that µ1 was 
being cleaved by activated caspases and that epitopes recognized by the anti-reovirus 
serum were being destroyed. 
To further explore this possibility, I examined the forward and side scatter 
characteristics of CHO-S cells transiently expressing μ1 by flow cytometry. I noted 
two subpopulations of cells with distinctive forward and side scatter characteristics, 
which were absent in the vector-only-transfected and µ1δ-expressing cells (Figure 
4.1C, vector only not shown). One subpopulation of cells that represented 23.6% of 
the total had relatively low forward scatter and increased side scatter, characteristics 
that are often seen in cells undergoing early apoptosis (8). However, when the total 
population was gated for expression of μ1, only 8.9% of the low forward scatter and 
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increased side scatter subpopulation were µ1 positive (Figure 4.1C, top left panels). 
When cells expressing µ1 were treated with the pan-caspase inhibitor q-VD-Oph the 
subpopulation with low forward and high side scatter disappeared or diminished 
suggesting that these cells were indeed apoptotic (Figure 4.1C, top right panels). In 
addition, treatment of cells transfected with µ1 with pan-caspase inhibitor significantly 
increased the numbers of cells expressing µ1 (Figure 4.1D left panel). I considered 
two possible explanations for these findings: (i) µ1 was inducing apoptosis directly in 
cells, but its levels were subsequently decreased below the levels of detection by 
proteolytic cleavage of the epitopes being recognized or (ii) cells expressing µ1 caused 
bystander apoptosis in surrounding cells. Bystander apoptosis has been reported 
during reovirus infection of HeLa cells (3). To directly address the possibility that 
cells expressing µ1 released factors that induced bystander apoptosis, I collected 
media from µ1- or µ1δ-expressing cells at 24 h post-transfection and incubated this 
media with fresh untransfected cells. I found that media collected from µ1-transfected 
cells had no effect on untransfected cells (data not shown). Taken together these 
results suggest that µ1 induces apoptosis and is then itself degraded by activated 












Figure 4.1: Effect of a pan-caspase inhibitor on the expression levels of µ1 and light 
scatter characteristics of cells expressing µ1. A) Diagram of µ1 cleavage fragments; 
B) Immunoblot of lysates from 293F cells expressing µ1 or µ1δ and treated with 
DMSO or q-VD-Oph. 293F cells were transfected with plasmids encoding µ1 or µ1δ 
and then treated with 10 µM q-VD-Oph or an equal volume of DMSO. Cells were 
harvested 24 h post-transfection and lysates were prepared and immunobloted. µ1 or 
µ1δ were detected with rabbit anti-reovirus serum followed by IRDye 680 conjugated 
goat anti-rabbit IgG. Fluorescence emission from bound fluorescent antibody was 
detected using an infrared gel scanner (Odyssey, LI-COR). Bracket indicates high 
molecular weight banding. Circles denote immunoreactive bands of lower molecular 
weight than full-length µ1. C) Effect of q-VD-Oph on the forward and side scatter 
characteristics of cells expressing μ1 or µ1δ. CHO-S cells were transfected with the 
indicated plasmids. At 24 h post-transfection, cells were harvested, fixed, 
immunostained for µ1 and analyzed by flow cytometry. Cells positive for µ1 or µ1δ 
were gated (10,000 events) and their side and forward scatter characteristics compared 
to those of the total cell population. The percentage of µ1-positive cells present within 
the outlined regions is indicated. D) Histogram of µ1 or µ1δ expressing CHO-S cells 
with DMSO or q-VD-Oph treatment. Cells were transfected with the indicated 
plasmids and then treated with 10 µM q-VD-Oph (black line) or an equal volume of 
DMSO (grey line). At 24 h post-transfection, cells were harvested, fixed, 










My results thus far indicated that the low levels of immunoreactive μ1 might 
be explained by loss of the epitope recognized by anti-reovirus serum following 
proteolytic cleavage by caspases. Monoclonal antibodies raised against virions that 
recognize μ1 recognize the δ region of μ1 (32). To test this hypothesis, I examined the 
steady state expression levels of μ1 fusion proteins in which EGFP was fused to the C- 
or N-terminus (fused to residue 2) of μ1 (using pEGFP-N-M2(N) and pEGFP-C-
M2(N) vectors, respectively) in transfected 293F cells (Figure 4.2A). The subcellular 
distribution of EGFP-μ1 and μ1-EGFP were similar to that of wild type μ1 when 
expressed in cells and both fusion proteins were recognized by mAb anti-µ1 10H2 
(Figure 4.2B), suggesting that the fusion had not substantially altered the folding of 
μ1. Similar to wild type μ1, the levels of full-length μ1-EGFP and EGFP-μ1 when 
detected with an anti-reovirus serum or an anti-GFP antibody increased upon 
treatment with q-VD-Oph (Figure 4.2A). However, when the fusion proteins were 
detected with anti-GFP antibodies, bands of lower molecular weight than the full-
length fusion protein, but larger than EGFP alone were detected, particularly in the μ1-
EGFP lysates (Figure 4.2A). Although additional faint lower molecular weight bands 
were detected in the EGFP-μ1 lysates probed with anti-GFP, there were at least six 
additional lower molecular weight bands of greater intensity present in μ1-EGFP 
lysates. These findings supported my hypothesis that μ1 was being proteolytically 
cleaved and that fragments of lower molecular weight were no longer recognized by 
the anti-reovirus serum, but were recognized by the anti-GFP serum. In addition, when 
I compared the banding pattern of μ1-EGFP in immunoblots probed with anti-GFP 
antibodies in the presence or absence of q-VD-Oph it was clear that some lower 
molecular weight bands became more intense in the presence of q-VD-Oph and at 
least one lower molecular weight band present in lysates from cells without q-VD-Oph 
became less intense in lysates from cells treated with q-VD-Oph. Taken together these 
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findings confirm that μ1 was being cleaved by q-VD-Oph-inhibitable proteases, most 
likely caspases, and suggest that this cleavage was occurring predominantly towards 




Figure 4.2: Comparison of the expression levels of µ1, µ1-EGFP and EGFP-µ1 in 
293F cells treated with DMSO or q-VD-Oph. A) Immunoblots of 293F cells 
expressing µ1, EGFP, EGFP-µ1, and µ1-EGFP. 293F cells were transfected with 
plasmids for the indicated proteins and treated with 10 µM q-VD-Oph or an equal 
volume of DMSO. At 24 h post-transfection, lysates were prepared, immunoblotted 
and probed with rabbit anti-reovirus serum and mouse anti-GFP followed by IRDye 
680 goat anti-rabbit IgG and IRDye 800CW goat anti-mouse IgG. Fluorescence 
emission from bound fluorescent antibodies was detected using an infrared gel scanner 
(Odyssey, LI-COR). Arrows indicate full length proteins (µ1 o EGFP), arrowheads 
indicate cleavage fragments. B) Immunofluorescence images of the subcellular 
distribution of µ1, EGFP-µ1, and µ1-EGFP in transfected CV-1 cells. CV-1 cells on 
glass cover slips were transfected with plasmids for the indicated proteins. At 24 h 
post-transfection the cells were fixed and immunostained for µ1 or the intrinsic 
fluorescence of EGFP was detected. Scale bars, 10 µm. 
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µ1 expressed in transfected cells is ubiquitinated. In addition to low 
molecular weight bands, I also noted the appearance of a high molecular weight smear 
if µ1-expressing cells were treated with the pan-caspase inhibitor q-VD-Oph. The 
presence of these high molecular weight bands in the μ1-transfected cell lysates 
suggested that μ1 was ubiquitinated. Therefore, I co-expressed full-length μ1 with a 
his-tagged polyubiquitin-encoding plasmid and precipitated his-polyubiquitin-tagged 
proteins from the lysates with Ni-NTA agarose. Immunoblots of co-precipitated 
proteins probed with anti-reovirus serum revealed that µ1 was pulled down along with 
his-polyubiquitin (Figure 4.3A). As controls I expressed µ1 or the his-polyubiquitin 
plasmid with empty vector or co-expressed µ1 with his-tagged c-jun protein. µ1 was 
not precipitated if expressed alone, indicating µ1 did not interact with the Ni-NTA 
resin non-specifically. Co-expression with c-jun-his did also not result in µ1 
precipitation ensuring that the his-tag was not responsible for the interaction seen 
between µ1 and his-polyubiquitin. The amount of detectable µ1 in the precipitation 
was low, as seen before in transfected cells. Therefore, I treated cells at the time of 
transfection with q-VD-Oph and repeated the precipitation assay. I saw a dramatic 
increase in the level of ubiquitinated µ1 under conditions of caspase inhibition (Figure 
4.3B, note 15 min vs. 1 min exposure). This increase of ubiquitinated µ1 did not 
reflect an overall augmentation of ubiquitination, as treatment of his-polyubiquitin 
expressing cells with q-VD-Oph did not alter the amount of ubiquitinated protein that 
was precipitated (Figure 4.3C). I conclude from these results that μ1 is 
polyubiquitinated and likely targeted for proteasome-mediated degradation. In support 
of these findings, I found that polyubiquitin co-localized with μ1 in transfected and 
infected cells on ring-like structures in the cytosol of cells (Figure 4.4). It has been 











Figure 4.3: µ1 is ubiquitinated. 293F cells were transfected with plasmids expressing 
the indicated proteins and then treated with A) DMSO or B) 10 µM q-VD-Oph at the 
time of transfection. Cell lysates were prepared and his-ubiquitin-tagged conjugates 
were isolated from equal amounts of protein by Ni-NTA chromatography as described 
in Materials and Methods. The isolated conjugates were separated on SDS-
polyacrylamide gels and immunoblotted for µ1 and the polyhistidine epitope tag using 
the indicated antibodies. Lysate only lane (Lys) shows expression of µ1. High 
molecular weight bands indicative of polyubiquitination are bracketed. Asterisks 
indicate non-specific immunoreactive bands. C) q-VD-Oph treatment does not 
increase the levels of polyubiquitination. 293F cells were transfected with a His-
polyubiquitin expressing plasmid and treated with DMSO or 10 µM q-VD-Oph at the 
time of transfection. His-polyubiquitinated proteins were precipited using Ni-NTA 
agarose, immunoblotted and probed with anti-6xHis antibody. Note that blots in A) 
















Figure 4.4: Co-localization of µ1 and polyubiquitin. A) Immunofluorescent images of 
mock, T3DCD, and T1L-infected HeLa cells. B) Immunofluorescent images of M2-
transfected HeLa cell. Cells on cover slips were infected (MOI = 5) or transfected as 
indicated, then fixed and immunostained with anti-µ1 mAb 4A3 (isotype IgG2b) and 
mAb FK1 (isotype IgM). Primary antibodies were detected with Alexa-594 conjugated 
goat anti-mouse IgG2b and FITC-conjugated goat anti-mouse IgM, respectively. Scale 
bars, 10 µm. 
 
Mutations at predicted caspase cleavage sites at residues 487 and 490 of µ1 
stabilize protein levels in transfected cells. Based on my findings, I hypothesized 
that μ1 was a target for caspases and thus contained caspase cleavage sites. To test this 
hypothesis, I analyzed the μ1 amino acid sequence for potential caspase cleavage sites 
using three prediction algorithms. The predicted cleavage sites were not randomly 
distributed throughout the protein, but were clustered within the δ region and no 
predicted sites were present between residues 582-611, the minimal region of Φ 
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required for μ1-induced apoptosis (5). Using this information, I prepared twelve point 
mutations in which the predicted P1 aspartate residue was mutated to either an alanine, 
asparagine, glutamate or lysine. All of the mutants were expressed and had a 
subcellular distribution similar to that of wild type μ1 (data not shown). I screened the 
expression levels of these mutants in CHO-S cells by flow cytometry (Figure 4.5A and 
B) and found that three mutants, D487N, D490E, and D490N had significantly higher 
expression levels than wild type μ1 when assessed as fold-change in geometric mean 
fluorescence (Figure 4.5A) and also in the percentage of cells expressing detectable μ1 
(Figure 4.5B). These results correlated with immunoblot results from transfected 293F 
cells (a subset of mutants is shown in Figure 4.5C). In the presence of q-VD-Oph, I 
noted a significant eight-fold increase in the percentage of cells expressing wild type 
μ1. In contrast, although there was a 1.5 to 3-fold increase in expression of mutants 
D487N, D490E, and D490N in the presence of q-VD-Oph, this was significantly less 
than the increase seen for wild type and the null mutants D191A (see Figure 4.5C) and 
D97E (Figure 4.6A and B). This result suggested that amino acids 487-490 was a 
caspase cleavage site, as mutation of this motif diminished the responsiveness of µ1 to 



















Figure 4.5: Expression of µ1 and mutants in CHO-S and 293F cells treated with 
DMSO or q-VD-Oph. A) Normalized change in mean fluorescence index of CHO-S 
cells expressing WT and mutant forms of µ1. B) Percentage of cells expressing µ1. 
CHO-S cells were transfected with plasmids expressing the indicated WT and mutant 
forms of µ1 and treated with 10 µM q-VD-Oph or an equal volume of DMSO. At 24 h 
post-transfection the cells were fixed, immunostained for µ1 and analyzed by flow 
cytometry. C) Immunoblots of µ1 and indicated mutants expressed in 293F cells 
treated with DMSO or 10 µM q-VD-Oph at the time of transfection. Blots were 



















Figure 4.6: A) Effect of q-VD-Oph on the percentage of WT or mutant-transfected 
cells expressing µ1. B) Data in A) expressed as fold increase in percentage of cells 
expressing µ1 in the presence of q-VD-Oph. Data shown are the means and standard 
deviations of a minimum of three independent experiments. * p < 0.05. 
 
Given these findings I predicted that the cleavage pattern of μ1 would differ in 
the mutants D487N, D490E and D490N. To test this hypothesis I prepared constructs 
in which EGFP was fused to the C-terminus of these mutants and examined their 
cleavage pattern in transfected 293F cells in the presence or absence of q-VD-Oph 
(Figure 4.7). I found that, in contrast to wild type μ1, the immunodetectable levels of 
μ1 did not change as markedly in the presence of q-VD-Oph. For all mutants and the 
wild type, a number of small molecular weight bands were detected by immunoblot 
both with and without caspase inhibitor, suggesting μ1 had been cleaved by other 
proteases. Both the wild type and mutant D191A exhibited a slightly different pattern 
of low molecular weight bands upon q-VD-Oph addition, while the fragment banding 
pattern for mutants D487N, D490E and D490N remained the same. This finding 










Figure 4.7: Cleavage patterns and expression levels of µ1-EGFP and mutants in the 
absence or presence of a pan-caspase inhibitor. A) anti-reovirus immunoblot B) anti-
GFP immunoblot C) two-color fluorescent immunoblot (red = anti-reovirus; green = 
anti-GFP) D) comparison of banding pattern for µ1-EGFP lysates immunostained for 
µ1 and GFP [data derived from panels A) and B)]. The indicated plasmids were 
transfected into 293F cells that were treated with 10 µM q-VD-Oph or an equal 
volume of DMSO. 24 h post-transfection cell lysates were prepared, immunoblotted 
and probed with rabbit anti-reovirus (T3D) serum and mouse mAb anti-GFP followed 
by IRDye 680 goat anti-rabbit IgG and IRDye 800CW goat anti-mouse IgG. 
Fluorescence emission from bound fluorescent antibodies was detected using an 
infrared gel scanner (Odyssey LI-COR). Brackets in panels A) and B) indicate high 
molecular weight banding. The filled arrowheads in B) indicate EGFP and the empty 
arrowhead indicates ~ 37 kDa band. In panel D) arrows indicate bands not detected 















Capacity of wild type and mutant forms of µ1 to induce apoptosis in 
transfected cells. The μ1 mutants D487N, D490E and D490N were expressed at 
higher steady-state levels than wild type μ1 in transfected cells. Therefore, I examined 
the possibility that these mutants would induce greater levels of apoptosis in 
transfected CHO-S cells. I found that mutants D97E, D490E and D490N induced 
similar levels of caspase 3/7 activity in CHO-S cells as wild type μ1 (Figure 4.8A). 
However, mutant D487N induced significantly lower mean levels of apoptosis than 
wild type μ1 (38.6 vs 23.8 %). When I analyzed cells that were caspase 3/7 positive, I 
found that mutants D487N, D490E, and D490N had a higher percentage of cells that 
were μ1 positive and a lower percentage of cells that were μ1 negative in comparison 
to cells transfected with wild type μ1 or mutant D97E (Figure 4.8B), indicating that 
more μ1 was detectable in cells expressing mutants D487N, D490E, and D490N. This 
observation was concurrent with the results in wild type µ1 where treatment with the 
pan-caspase inhibitor q-VD-Oph increased the number of cells with detectable levels 
of µ1 (Figure 4.1D). 
Mutant forms of µ1 cause less cytotoxicity than wild type µ1. When I 
investigated the overall number of dead cells in wild type compared to mutant µ1 
expressing CHO-S cells, I found that there was a significant difference. Caspase 
cleavage mutants D487N, D490E and D490N showed a reduction in the number of 
dead cells while the null mutant D97E caused cell death to an extent similar to wild 
type µ1 (Figure 4.8C). This was a surprising result given my finding that the caspase 
cleavage mutants (except D487) were as effective in inducing caspase 3/7 activation 
as wild type µ1. I hypothesize that wild type µ1 causes cell death not only by inducing 
apoptosis, but might also have other cytotoxic effects which are no longer available to 





Figure 4.8: µ1 mutants deficient for cleavage at residue 490 activate caspase 3/7 as 
efficiently as wild type, but induce less cytotoxicity. A) Percent cells with active 
caspase 3/7 expressing the indicated plasmids with or without caspase inhibitor, V 
denotes empty vector. B) Distribution of active caspase 3/7 positive cells according to 
the detectability of wild type or mutant µ1 expression. Caspase 3/7 activation was 
analyzed with FLICA caspase3/7 kit. C) Percent cytotoxicity in cells expressing the 
indicated plasmids, V denotes empty vector. Cell viability was analyzed with 
Live/Dead Cell Viability Kit. CHO-S cells were transfected with plasmids expressing 
the indicated wild type and mutant forms of µ1 or µ1δ and treated with 10 µM q-VD-
Oph or an equal volume of DMSO. At 24 h post-transfection the cells were fixed, 
immunostained for µ1 and analyzed by flow cytometry. 
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Mutant forms of µ1 have an ubiquitination defect. I showed before that µ1 
was ubiquitinated and that ubiquitination increased substantially after treatment with 
the pan-caspase inhibitor q-VD-Oph. Thus, I investigated if the caspase cleavage 
mutants responded similarly. I co-expressed the caspase cleavage mutants with His-
polyubiquitin and purified His-polyubiquitin-tagged proteins through Ni-NTA 
chromatography. I found that the D487A mutant showed increased ubiquitination in 
the absence of q-VD-Oph compared to wild type µ1 (Figure 4.9A left panel). After 
treatment with q-VD-Oph, however, the extent of ubiquitination of the D487 mutant 
did not increase further as seen for wild type µ1 (Figure 4.9A right panel). The 
seemingly different level of ubiquitination in D487N versus D487A µ1 in Figure 4.9A 
could be explained by the different exposure time of the two immunoblots. Although 
prevention of caspase cleavage through mutation of amino acid D487 did lead to 
similarly increased ubiquitination of µ1 as caspase inhibition had, the mutation of aa 
D490 led to a different phenotype. This mutation, although targeting the same caspase 
cleavage site as the mutation of aa D487, did not show increased ubiquitination in the 
absence of q-VD-Oph (Figure 4.9A left panel). This phenotypic incongruence 
prompted me to consider that the D487 mutant might be misfolding and thus was 
ubiquitinated more strongly than wild type µ1. In support of this hypothesis, I found 
that the mutants D487N and D487A had severe defects in µ1:σ3 co-
immunoprecipitation assays, indicating that a mutation at residue 487 abolished the 
capacity of µ1 to assemble with σ3 (data not shown). Mutation of residue 490 did not 
only not increase ubiquitination of µ1, but also abrogated the ubiquitination-enhancing 
effect of q-VD-Oph treatment seen in wild type µ1 (Figure 4.9A). These findings 
suggested that prevention of caspase cleavage by a chemical inhibitor and by mutation 
of the cleavage site caused two different phenotypes, inhibiting the enzyme increased 
ubiquitination while mutation of the target reduced ubiquitination. 
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Nonetheless, both scenarios implied a link between caspase activity and 
ubiquitination. In order to test whether the reduction in ubiquitination was confined to 
mutation of the caspase cleavage site, I constructed several alanine substitution 
mutants (aa 485-495) targeting residues up- and downstream of the D490 cleavage 
site. The amino acid 491 is already an alanine and was thus not mutated. The alanine 
mutants were co-expressed with His-polyubiquitin and analyzed for their 
ubiquitination status with or without q-VD-Oph treatment. Figure 4.9B shows that 
mutant D487A was again highly ubiquitinated in comparison to wild type µ1, but also 
that mutation of the preceding residues, Q485 and P486 caused more ubiquitination 
than wild type µ1 in the absence of the caspase inhibitor. This could indicate that this 
region does not tolerate mutations and that substitutions lead to misfolding and 
ubiquitination. The mutation of residues 488 to 495 did not enhance ubiquitination in 
the absence of q-VD-Oph (Figure 4.9B) which suggested that these mutants were not 
misfolding. The mutants L492A and T494A seemed to be even less ubiquitinated then 
wild type µ1, which might have been due to lower expression levels (lysate Figure 
4.9B). In the presence of q-VD-Oph the mutants V488A and M495A behaved like 
wild type µ1 and showed a strong increase in ubiquitination (Figure 4.9C). Mutation 
of residues 493 and 494 led to a moderate reduction in ubiquitination while the 
mutations closest to aa 490 (W489A, L492A) caused a severe reduction in 
ubiquitination (Figure 4.9C). This result suggested that the effect of decreased 
ubiquitination was tightly linked to the mutation of the D490 caspase cleavage site. I 
also noted that all mutants that exhibited a defect in ubiquitination lacked a lower 
molecular weight fragment of µ1 seen in the lysate, with the exception of the D487A 
mutant which was highly ubiquitinated as a consequence of misfolding (lysate Figure 
4.9C). The concurrence of µ1 cleavage inhibition and ubiquitination reduction further 











Figure 4.9: Caspase cleavage mutants exhibit an ubiquitination defect. 293F cells were 
transfected with the indicated plasmids and a His-polyubiquitin-expressing plasmid 
and treated with A) right and C) 10 µM q-VD-Oph or A) left and B) an equal volume 
of DMSO. 24 h post-transfection lysates were prepared and His-polyubiquitinated 
proteins were precipitated, immunoblotted and probed with anti-reovirus serum. Equal 
amounts of protein were used in precipitations. Note that blots have different exposure 
times, 15 min without q-VD-Oph and 1 min with q-VD-Oph. Mutants were alanine, 
asparagine or glutamate substitutions of amino acids in the caspase cleavage site (aa 
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Generation and initial characterization of a µ1-D490E mutant virus. In 
order to investigate the biological significance of the caspase cleavage site mutation, I 
used reverse genetics to generate a virus that carries the D490E mutation in its M2 
gene segment (20). I was not able to recover virus with the other mutations, D191A, 
D487N and D490N. As a first step to characterize the D490E mutant virus I performed 
single and multiple cycle growth kinetics. Overall there seemed to be no difference 
between the amount of virus produced in a single cycle of replication of wild type and 
mutant virus (Figure 4.10C). I harvested the supernatant in the single cycle growth 
kinetics separately from the cells in order to distinguish between released and cell-
associated virus. I found that at early times after infection, there was more virus 
released in the mutant than the wild type virus (Figure 4.10B). This release however 
occurred so early at 3 h post-infection that this virus likely constitutes input virus and 
not newly generated virions. I hypothesize that the D490E mutant virus was initially 
bound to cells, but did not become internalized and ultimately detached from the cell 
into the supernatant. If the D490E mutation causes an entry defect will be investigated 
using a hemolysis assay. The amount of cell-associated mutant virus was reduced by 
approximately half a log which may be due to the proposed entry defect of the mutant 
(Figure 4.10A). In addition, there seemed to be a slight delay in virus release from the 
D490E-infected cells; see right shift of D490E curve in Figure 4.10A. The analysis of 
the multiple cycle growth kinetic revealed that the D490E mutant virus grew to 
significantly lower titers when compared to wild type virus (Figure 4.10D). If the 








Figure 4.10: Single and multiple cycle growth kinetics of µ1-D490E mutant virus in 
comparison to recombinant wild type virus. A-C) Single cycle growth kinetics. L929 
cells were infected with recombinant wild type (WT) or D490E mutant virus at 
MOI=5. Supernatant and cells were harvested separately 3, 6, 9, 12, 24 and 48 h post-
infection. D) Multiple cycle growth kinetics. L929 cells were infected with 
recombinant wild type (WT) or D490E mutant virus at MOI=0.1. Cells with 
supernatant were harvested 6, 12, 24, 48, 72 and 96 h post-infection. Titers were 
analyzed with standard plaque assay. Graphs show mean and standard deviation of 




Apoptosis in reovirus infection is not a host defense mechanism, but is induced 
by the virus. It is thought that apoptosis induction aids viral spread (26). In order for 
the virus to benefit from apoptosis, the induced cell death has to be regulated so that it 
does not occur too early before replication and assembly are completed. Coffey et al. 
showed that the reovirus outer capsid protein µ1 induces apoptosis if expressed 
ectopically in cells (5). It has also been demonstrated that µ1 is responsible for 
apoptosis induction in virus infection (7). I previously noted that the µ1 protein levels 
are substantially greater in infected cells than in cells ectopically expressing µ1. I 
speculated that µ1 might be unstable and degraded in transfected cells. Here I 
investigated possible mechanisms for µ1 degradation and found that µ1 is a target for 
cleavage by caspases and ubiquitination. Treatment of µ1 expressing cells with the 
pan-caspase inhibitor q-VD-Oph caused a 4-fold increase in the detectable levels of 
µ1. In addition I observed the appearance of a number of small molecular weight 
fragments and also a high molecular weight smear. Analysis of the primary amino acid 
sequence of µ1 revealed a dozen potential caspase cleavage sites, but mutational 
analysis confirmed only one site at amino acids 487-490. The fact that mutation of 
amino acids D487 and D490 led to a different cleavage pattern of the mutant µ1 
protein signified that this site was a functional caspase cleavage site. The high 
molecular weight smear seen in immunoblotting after treatment of µ1-expressing cells 
with pan-caspase inhibitor could be identified as ubiquitination of µ1. The extent of 
µ1 ubiquitination after caspase inhibition was dramatically increased. Given the fact 
that caspase inhibition did not increase the total amount of protein ubiquitination, I 
speculate that not only the amount of µ1 protein increased with caspase inhibition, but 
that ubiquitination was somehow facilitated as well. How caspase inhibition might 
augment ubiquitination remains to be elucidated. An example where caspase cleavage 
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and ubiquitination are linked has been demonstrated in the oncoprotein MDM2 and its 
substrate p53. MDM2 is an E3 ubiquitin ligase which ubiquitinates p53 and thus 
targets it for degradation (15). In apoptotic cells MDM2 is cleaved by caspase 3 into 
two subdomains, the N-terminal fragment which can still bind p53 and inhibit its 
function and the C-terminal fragment which contains the ubiquitin ligase activity (2). 
This region is no longer able to interact with p53 and thus, inhibition of caspase 3 
should prevent MDM2 cleavage and maintain its ubiquitination activity. So far no 
ubiquitin ligase has been identified that interacts or co-localizes with µ1. 
But it seems that the situation in the case of µ1 is more complicated. After 
identifying a caspase cleavage site at amino acid 490 I expected to see a similar 
increase in ubiquitination in a mutant of this cleavage site as I had for wild type µ1 
under conditions of caspase inhibition. Surprisingly, I found that D490 mutants did not 
show enhanced ubiquitination. Thus it appears that prevention of caspase cleavage by 
different means, chemical inhibition of the enzyme or mutation of the recognition site 
in the substrate, has different phenotypic outcomes. In contrast, the D487 mutant did 
exhibit strong ubiquitination when compared to wild type µ1 under conditions of 
active caspases. However, when I examined the caspase cleavage site mutants for their 
ability to interact with σ3, I found that the D487N mutant had a severe defect (data not 
shown). Thus, I hypothesize that this mutant might be misfolded, triggering 
ubiquitination. In order to explain the results seen for caspase cleavage inhibition by 
inhibitor or mutation I hypothesize that caspases function in two separate ways. The 
increase in ubiquitination of wild type µ1 after treatment with a pan-caspase inhibitor 
could suggest that caspases cleave and destroy an enzyme of the ubiquitination 
machinery responsible for ubiquitination of µ1. Simultaneously, caspase cleavage of 
µ1 seems necessary for ubiquitination as the mutation of the caspase cleavage site 
reduces ubiquitination. This would imply though that it is a cleavage fragment of µ1 
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that becomes ubiquitinated. Immunoblots of ubiquitinated µ1, however, do not show 
any small fragments, only bands that are larger than full length µ1. Taking into 
account that cleavage of µ1 seems to destroy immunoreactive epitopes, the lack of 
smaller ubiquitinated fragments of µ1 could be explained by their indetectability. 
Preliminary experiments with simultaneously N- and C-terminally tagged µ1 did 
indeed reveal the presence of ubiquitinated µ1 fragments of around 50 kDa. 
The caspase cleavage mutants at residue D487 and D490 did show an 
increased µ1 steady state levels in transfected cells. Surprisingly, although they 
activated caspases 3 and 7 to a similar extent as wild type µ1, they caused significantly 
less cytotoxicity. Coffey et al found that the C-terminal Φ fragment (amino acids 582-
708) of µ1 is necessary and sufficient for apoptosis induction (5). They also showed 
that this fragment alone exhibits a slightly different subcellular localization. Full 
length µ1 localized predominantly to lipid droplets and to a lesser extent to 
mitochondria and the endoplasmic reticulum (ER). Φ, however, demonstrated a 
preferential localization to mitochondria and less to lipid droplets and the ER (5). It 
seems possible that while full length µ1 is capable of activating caspases 3 and 7, 
cleavage of µ1 into a fragment that contains Φ enables this fragment to target 
additional membranes, thus causing increased cytotoxicity. It would be interesting to 
investigate the subcellular distribution of the different cleavage fragments of µ1 using 
a simultaneously N- and C-terminally tagged version of µ1. 
I was unable to recover recombinant viruses harboring the mutations D191A, 
D487N, D490E and D490N in their M2 gene segment. I was only able to recover the 
mutant virus D490E. The D191 residue is located in an α-helical region in the basal 
part of the µ1 trimer and is likely buried (21). A mutation might interfere with the 
proper folding and/or assembly of µ1. The amino aids D487 and D490 are in the head 
part of the µ1 trimer where the three jelly-roll β barrels arrange around a central 
 136 
channel of approximately 5 Å diameter (21). Residue D490 appears to face into this 
channel while D487 does not seem to be exposed. The D487N mutation most likely 
causes problems in the association of the three µ1 head domains. If this was the case, 
this mutant would certainly be defective in its ability to assemble with σ3, which is 
exactly what I found in µ1-D487N:σ3 co-immunoprecipitation assays (data not 
shown). It was surprising that I could recover the D490E mutant virus, but not the 
D490N variant. The µ1 head domain is thought to undergo a conformational change 
during virus entry which results in a more open conformation of this domain (21). It is 
possible that a glutamate at position 490 is more conducive to such a conformational 
change or the maintenance of either the closed or open status than an asparagine. 
Indeed, the D490E mutant virus did show a possible entry defect in single cycle 
growth kinetics, but these findings need to be addressed more specifically. 
In summary, I have provided evidence that µ1 is a target for caspase cleavage 
and ubiquitination and that both processes are somehow linked. Cleavage of µ1 also 
seems to regulate cytotoxicity. The exact mechanism and interconnectivity of these 
occurrences remains to be elucidated.  
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Summary and Future Directions 
 
µNS-Hsc70 interaction 
The involvement of chaperones in the reovirus life cycle has not been studied 
extensively. Although the cellular chaperones Hsp70 and Hsp90 have been found 
necessary for proper folding of the σ1 attachment protein, no further studies have 
looked at chaperones in other assembly or replicative processes (10). In chapter 2, I 
presented evidence that the constitutively expressed cellular chaperone heat shock 
cognate protein 70 (Hsc70) interacted with the viral factory (VF) matrix protein µNS. 
I showed that Hsc70 co-localized with viral factories in reovirus infected cells and also 
with viral factory-like structures (VFLs) formed by ectopic expression of µNS. A 
direct interaction between Hsc70 and µNS was confirmed using co-
immunoprecipitation. The interaction and co-localization of Hsc70 with µNS was 
independent of chaperone function. This indicated that although the minimal 
interaction domain in Hsc70 was mapped to the substrate binding site, µNS was not 
bound as a substrate for the chaperone. In general, chaperones recognize exposed 
unfolded hydrophobic regions present in proteins during synthesis or exposed in 
protein complex subunits prior to assembly into the full complex (7, 8). 
µNS is thought to form the matrix of VFs by oligomerization. But as an atomic 
structure of µNS is not available, the nature of such oligomers remains elusive. 
Therefore, it seems possible that Hsc70 is recruited to VFs in order to aid in the 
oligomerization of individual µNS proteins. I have found, however, that knockdown of 
Hsc70 had no detectable effect on viral factory formation or maintenance. The K71M 
dominant negative mutant of Hsc70 does not interact with substrates (11). My 
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hypothesis that µNS is not a substrate for Hsc70 is supported by my finding that this 
and other dominant negative mutants of Hsc70 co-localized and interacted with µNS. I 
mapped the minimal interaction domain in µNS to lie between amino acids 222-271. 
However, point mutants within this region in context of the full length protein or 
deletion of the region did not abrogate µNS interaction with Hsc70. The deletion of 
the middle part of the µNS protein might very well have led to misfolding of the 
protein and thus interaction with Hsc70. But given the fact that this truncation mutant 
also interacted with a dominant negative mutant of Hsc70, I believe that the 
association was not due to µNS misfolding. Based on this finding I hypothesize that 
there is a second Hsc70 binding domain in µNS. I suspect this second interaction 
domain lies between amino acids 272-470, as amino acids 1-221 and 471-721 did not 
interact with µNS. To investigate this hypothesis I have generated a plasmid encoding 
amino acids 272-470 in order to assess its capacity to interact with Hsc70. If this 
fragment associated with Hsc70, this would also explain why point mutants in the 
amino acid region 222-271 did not show an effect in context of the full length protein. 
Almost all experiments in Chapter 2 were performed with ectopically 
expressed proteins. Although we demonstrated a co-localization of Hsc70 and viral 
factories and co-immunoprecipitated Hsc70 and µNS from infected cells, the 
biological significance of the interaction of Hsc70 with µNS has not been addressed. 
One possibility to investigate the role of Hsc70 µNS interaction in infection would be 
to transfect cells with dominant negative mutants of Hsc70 or siRNA against Hsc70 
and evaluate changes in viral titer. However, such experiments might not show any 
difference in viral output. Given the fact that the inducible form of Hsc70, heat shock 
protein 70 (Hsp70) also co-localizes with viral factories (data not shown) it seems 
possible that Hsp70 could compensate for the loss of Hsc70 and mask a potential 
phenotype. On the other hand if knockdown of Hsc70 with subsequent infection does 
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exhibit a change in viral production, it would be impossible to attribute this result to 
the interruption of the µNS Hsc70 interaction. 
As discussed in chapter 3, Hsc70 also interacts with the outer capsid protein µ1 
and the µ1:σ3 heterohexamer and also impacts the recruitment of σ3 to VFLs. 
Furthermore, Hsc70 aids in the final steps of µ1 removal from infecting virions (9). 
Thus knockdown of Hsc70 during infection would very likely affect more than only 
µNS-associated tasks of Hsc70, but might also interfere with heterohexamer assembly 
and possibly recruitment to viral factories. In order to specifically investigate the 
purpose of Hsc70 at viral factories, we would have to target the µNS protein and find 
mutants that no longer recruit Hsc70 and generate recombinant virus. Single point 
mutants in the so far identified interaction domain of µNS still bound Hsc70, but 
multiple mutations might be able to abrogate the association. Although the prior 
mutants of µNS still associated with Hsc70 in vitro, it is possible that these mutants 
would affect the function of µNS in the context of infection. Also, if region 272-470 
harbored a second interaction domain, additional mutations in this region could 
complement point mutants within amino acids 222-271 and abolish Hsc70 interaction. 
However, if Hsc70 serves a vital role at viral factories, the complete abrogation of 
association might prevent the recovery of recombinant virus. On the other hand, if 
such a defective virus could be rescued by expression of wild type µNS in trans, it 
might give insights into early assembly processes of reovirus as µNS has been found 
early in infection in complexes containing viral mRNA, σ3 and σNS (1). 
 
µ1-Hsc70 interaction and Hsc70 influence on σ3 trafficking 
The processes during assembly of the outer capsid proteins µ1 and σ3 and their 
recruitment to viral factories are largely unknown. Coffey et al have showed that µ1 
depends on σ3 for its recruitment to viral factories (3). They further described a role 
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for Hsc70 in recruitment of σ3 to viral factory-like structures (3). In chapter 3, I 
expanded on these findings and showed that Hsc70 interacted with the outer capsid 
protein µ1 alone and with µ1 in complex with σ3. I was able to co-immunoprecipitate 
µ1 using an anti-Hsc70 antibody and likewise Hsc70 using an anti-µ1 antibody. Given 
the fact that Hsc70 over-expression increased the frequency of σ3 co-localization with 
µNS VFLs, I expected to find an interaction between σ3 and Hsc70 (3). However, I 
could not detect any association of these two proteins by immunoprecipitation. I was 
able to co-immunoprecipitate σ3 with Hsc70 in the presence of µ1. Both µ1 and σ3 
were pulled down from infected as well as transfected cells using an anti-Hsc70 
antibody. These findings indicated that Hsc70 interacts with the µ1:σ3 heterohexamer 
via association with µ1. I also demonstrated that Hsc70 co-localized with µ1 on lipid 
droplets. This co-localization was dependent on chaperone function as dominant 
negative mutants of Hsc70 did not localize with µ1 on lipid droplets. I investigated if 
µ1 localization to lipid droplets was dependent on Hsc70, but found that siRNA-
mediated knockdown of Hsc70 or over-expression of dominant negative mutants of 
Hsc70 did not abrogate µ1 association with lipid droplets. 
Further investigations will aim to unravel the role of Hsc70 in µ1:σ3 
heterohexamer assembly and recruitment to viral factories. Hsc70 localization to µ1 
on lipid droplets suggests that these membranous structures could be the location of 
chaperone-aided heterohexamer assembly. In order to test this hypothesis I plan on 
using in vitro transcription and translation of µ1 and σ3 to assess their capacity to 
associate in the absence or presence of membranes. Preliminary experiments revealed 
that µ1 and σ3 form a complex and can be co-immunoprecipitated from reticulocyte 
lysates in the absence of membranes. Next, I will investigate if the addition of 
membranes in the form of microsomes changes the efficiency of µ1-σ3 co-
immunoprecipitation. In a similar fashion I would like to address the hypothesis that 
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Hsc70 is necessary for µ1:σ3 heterohexamer formation. One possibility is to assess the 
efficiency of µ1:σ3 co-immunoprecipitation in transfected cells after siRNA-mediated 
knockdown of Hsc70. If Hsc70 was necessary for µ1:σ3 assembly, then co-
immunoprecipitation of the two proteins should be reduced while immunoprecipitation 
of the individual proteins would be unaffected. However, as the transfection efficiency 
after siRNA treatment is diminished, µ1 and σ3 expression might be too low to detect 
µ1 and σ3 after immunoprecipitation. Another approach could be the triple 
transfection of µ1, σ3 and a dominant negative mutant of Hsc70 in order to prevent 
endogenous wild type Hsc70 from aiding in the heterohexamer formation. As there is 
no guarantee though that all µ1/σ3-expressing cells will also express dominant 
negative Hsc70, the result could be skewed by the presence of a population of cells in 
which µ1:σ3 complex formation can occur under normal Hsc70 conditions. 
Alternatively, reticulocyte lysate could be immunodepleted of chaperones and used for 
simultaneous in vitro transcription/translation of µ1 and σ3 followed by co-
immunoprecipitation of µ1 and σ3. Immunodepletion would ensure a uniform, 
chaperone-free environment for µ1:σ3 interaction. In addition, by also 
immunodepleting Hsp70, I could rule out possible substitution effects of Hsp70 for 
Hsc70. 
An interesting topic for further exploration is the relationship between Hsc70 
and σ3. There is no obvious co-localization between σ3 and Hsc70 as they are both 
distributed diffusely in the cytosol and nucleus. There also seems to be no physical 
interaction connecting these two proteins. Still, Coffey et al showed that Hsc70 over-
expression impacts σ3 localization to viral factory-like structures (3). My preliminary 
data indicate that the co-localization of σ3 and VFLs is an artifact of the fixation of 
cells with paraformaldehyde. In cells fixed with methanol the association of σ3 with 
VFLs is abolished even with over-expression of Hsc70. Nevertheless, the increase in 
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localization of σ3 to VFLs with Hsc70 over-expression in cells fixed with 
paraformaldehyde was a reproducible finding. Given that Hsc70 does not seem to 
interact with σ3, this suggests that the association of Hsc70 with the VFLs influences 
the frequency of σ3-VFL co-localization. In chapter 2, I showed that Hsc70 interacts 
with µNS and is recruited to VFLs and VFs. Thus it seems possible that the effect of 
Hsc70 on σ3 recruitment to VFLs actually reflects a role of Hsc70 in viral factory 
dynamics. The idea is that Hsc70 modulates the permeability of the viral factory µNS 
matrix in order to facilitate the admittance of viral proteins. A mutant of µNS that no 
longer associated with Hsc70 could provide information about this hypothesis. 
Alternatively, if such a mutant remains elusive, I could investigate if over-expression 
of Hsc70 has a similar enhancing effect on the recruitment of other proteins to VFLs. I 
found in chapter 2 that the ATPase domain of Hsc70 co-localizes to VFLs in an 
artifactual manner akin to σ3. Both proteins exhibit co-localization with VFLs after 
paraformaldehyde but not methanol fixation. If the Hsc70 ATPase domain co-
localized more frequently with VFLs after over-expression of Hsc70, this would 
support my hypothesis that Hsc70 increases the permeability of VFLs. 
 
µ1 caspase cleavage and ubiquitination 
Many studies focused on the different pathways contributing to reovirus 
induced apoptosis, but less attention has been directed towards the regulation of 
apoptosis. Apoptosis is induced late in infection and µ1 has been found to be the 
determining factor of reovirus induced cell death (4, 5). In chapter 4, I presented 
evidence that µ1 was a target for caspases and was also ubiquitinated. I showed that 
expression levels of µ1 increased after treatment of µ1-expressing cells with a pan-
caspase inhibitor. I had also found a discrepancy between the number of apoptotic 
cells after µ1 expression and the number of cells actually being positive for µ1. A 
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subpopulation of apoptotic cells did not register positive for µ1 expression. My 
hypothesis was that activated caspases during apoptosis cleave µ1 and destroy the 
immunoreactive epitope. EGFP-labeling of µ1 at either the N- or C-terminus revealed 
that there were indeed µ1 fragments generated during apoptosis that were only 
detected with an anti-GFP antibody, but not by an anti-reovirus serum. Mutation of 
several potential caspase cleavage sites in µ1 revealed one site, amino acids 487-490, 
that upon mutation caused a similar increase in detectable µ1 protein levels. 
Additionally, point mutants at position 487 or 490 exhibited a different banding 
pattern than wild type µ1 indicating that mutation of this site abolished cleavage of µ1. 
Mutants of this caspase cleavage site induced similar levels of caspase 3/7 activation, 
but caused significantly less cytotoxicity. I also showed that µ1 was ubiquitinated and 
that ubiquitination increased dramatically after treatment of µ1-expressing cells with a 
pan-caspase inhibitor. However, ubiquitination of the caspase cleavage mutant D490 
was not increased in the absence or presence of caspase inhibitor compared to wild 
type µ1. The lack of ubiquitination enhancement after caspase inhibition was 
correlated to the abrogation of µ1 cleavage at residue 490. Alanine substitution 
mutants surrounding amino acid D490 that were no longer cleaved also showed a 
defect in ubiquitination. The generation and initial characterization of a recombinant 
reovirus carrying the µ1-D490E mutation revealed a possible entry defect of this virus. 
Very soon after infection, too early to constitute newly generated virions, more virus 
was found in the supernatant of D490E than wild type virus infected cells. I 
hypothesize that this virus was initially bound to the cell surface, but was unable to 
infect the cell and ultimately detached into the supernatant. The mutant virus also 
grew to lower titers in multiple cycle growth kinetics which might be a due to the 
suspected entry defect. 
 148
Many questions about the role of caspase cleavage and ubiquitination of µ1 
remain. How are the two phenotypes related? The inhibition of caspase cleavage by 
pan-caspase inhibitor increased µ1 ubiquitination which indicated that active caspases 
have a negative effect on µ1 ubiquitination. However, mutation of the caspase 
cleavage site did not increase µ1 ubiquitination which suggests that µ1 needs to be 
cleaved to be efficiently ubiquitinated. So far it is also unclear which ubiquitin ligase 
and which caspase µ1 is targeted by. Tandem-affinity purification studies on µ1 did 
not identify any known ubiquitin ligase (Amaro and Parker unpublished data). In order 
to determine which caspase cleaves µ1, I intend to immunoprecipitate µ1 and then 
incubate the protein with different, active, recombinant caspases and evaluate possible 
fragments by immunoblotting. 
It would also be interesting to investigate the subcellular distribution and 
ubiquitination status of the individual µ1 caspase cleavage fragments, namely amino 
acids 1-490 and 491-708. The latter fragment contains the Φ domain which has been 
found to be necessary and sufficient for apoptosis induction (4). Ubiquitination and 
subsequent degradation of this Φ containing fragment might be a mechanism to 
regulate apoptosis induction by µ1. σ3 has been established as the protector protein of 
µ1, as µ1 no longer induces apoptosis when it is co-expressed with σ3 (3). Similarly, 
µ1 association with σ3 might prevent caspase cleavage and ubiquitination, if we 
assume that these modifications are only targeted towards free µ1. Although pan-
caspase inhibitor led to an increase in the detectable levels of µ1, there were still 
fragments of µ1 present. These fragments might be caused by cleavage due to residual 
caspase activity considering that the caspase inhibitor was added at the time of 
transfection and might have lost some of its potency over the 24 h time course of the 
experiment. This could be explored by adding caspase inhibitor repeatedly throughout 
the 24 h time period of the experiment to achieve a constant level of caspase 
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inhibition. Alternatively, µ1 could be cleaved by other proteases, possibly calpains 
which have been shown to be activated upon reovirus infection (6). It is unknown 
though if µ1 alone can also activate calpains. A surprising finding was that although 
the caspase cleavage mutants caused equal levels of activated caspase 3/7 compared to 
wild type µ1, they caused less cytotoxicity. It seems possible that µ1 causes cell death 
not only by inducing apoptosis, but has an additional cytotoxic potential and that the 
caspase cleavage mutants are less cytotoxic while preserving their apoptotic capacity. 
In order to establish a biological role for µ1 caspase cleavage and 
ubiquitination, it is necessary to fully characterize the µ1-D490E recombinant virus. 
Initial experiments revealed a possible entry defect of this mutant. This finding needs 
to be revisited with more specific experiments such as a hemolysis assay. Previous 
data generated in transfected cells have to be repeated in infected cells in order to 
address whether D490E-µ1 behaves similar in the context of infection. Such 
experiments include the extent of caspase 3/7 activation and cytotoxicity and the 
subcellular distribution, ubiquitination and fragmentation of mutant µ1. It would also 
be interesting to investigate the D490E mutant virus in animal infections and assess 
this virus for its capacity to spread, replicate and cause apoptosis and tissue damage in 
different organs. It is possible that the D490E mutation in µ1 has different effects in an 
in vitro versus an in vivo infection, similarly to a mutant virus which does not produce 
the non-structural protein σ1s. This σ1s-null virus shows no defect in replication in 
tissue culture, but is deficient in the dissemination from the intestine to the 
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